Monica Morrow
#30,239
Most Influential Person
American surgeon
Monica Morrow's AcademicInfluence.com Rankings
Philosophy
#3209
World Rank
#4725
Historical Rank
#1026
USA Rank
Logic
#1326
World Rank
#1942
Historical Rank
#388
USA Rank
Download Badge
Philosophy
Monica Morrow's Degrees
- Doctorate Medicine Harvard University
Why Is Monica Morrow Influential?
(Suggest an Edit or Addition)According to Wikipedia, Monica Morrow is a breast cancer surgeon and Chief of Breast Surgery at Memorial Sloan-Kettering Cancer Center in Manhattan, NY. Her first day seeing patients in clinic as Chief at MSKCC was Tuesday, February 19, 2008. She formerly served as the chairman of surgical oncology at the Fox Chase Cancer Center. She is the President-elect of the Society for Surgical Oncology.
Monica Morrow's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Papers
- Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 (2013) (2859)
- Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. (2011) (2624)
- The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation. (1999) (1638)
- Revision of the American Joint Committee on Cancer staging system for breast cancer. (2002) (1236)
- Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. (2010) (1113)
- Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial (2017) (932)
- The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women: Results From the MORE Randomized Trial (2000) (746)
- Continued Breast Cancer Risk Reduction in Postmenopausal Women Treated with Raloxifene: 4-Year Results from the MORE Trial (2004) (647)
- De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 (2018) (639)
- Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. (2014) (457)
- Regulatory T Cells Exhibit Distinct Features in Human Breast Cancer. (2016) (438)
- Inflammation and Increased Aromatase Expression Occur in the Breast Tissue of Obese Women with Breast Cancer (2011) (414)
- The Association of Surgical Margins and Local Recurrence in Women with Early-Stage Invasive Breast Cancer Treated with Breast-Conserving Therapy: A Meta-Analysis (2014) (401)
- High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants (2019) (397)
- Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. (2014) (394)
- Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases: Long-term Follow-up From the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 Randomized Trial (2010) (375)
- De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017. (2018) (353)
- Factors predicting the use of breast-conserving therapy in stage I and II breast carcinoma. (2001) (353)
- Does aggressive local therapy improve survival in metastatic breast cancer? (2002) (352)
- Patient involvement in surgery treatment decisions for breast cancer. (2005) (333)
- MRI for breast cancer screening, diagnosis, and treatment (2011) (324)
- Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ. (2009) (318)
- Clinical management factors contribute to the decision for contralateral prophylactic mastectomy. (2011) (310)
- Society of Surgical Oncology–American Society for Radiation Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stages I and II Invasive Breast Cancer (2014) (309)
- Standard for Breast Conservation Therapy in the Management of Invasive Breast Carcinoma (2002) (295)
- Staging system for breast cancer: revisions for the 6th edition of the AJCC Cancer Staging Manual. (2003) (291)
- Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline. (2013) (283)
- Consensus Statement on postmastectomy radiation therapy. (1999) (280)
- Career Satisfaction, Practice Patterns and Burnout among Surgical Oncologists: Report on the Quality of Life of Members of the Society of Surgical Oncology (2007) (275)
- Preoperative Magnetic Resonance Imaging in Breast Cancer: Meta-Analysis of Surgical Outcomes (2013) (271)
- Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials (2007) (268)
- Association of routine pretreatment magnetic resonance imaging with time to surgery, mastectomy rate, and margin status. (2009) (258)
- Surgeon recommendations and receipt of mastectomy for treatment of breast cancer. (2009) (245)
- Perceptions, Knowledge, and Satisfaction With Contralateral Prophylactic Mastectomy Among Young Women With Breast Cancer (2013) (243)
- Society of Surgical Oncology–American Society for Radiation Oncology–American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery with Whole-Breast Irradiation in Ductal Carcinoma In Situ (2016) (240)
- Increased levels of COX-2 and prostaglandin E2 contribute to elevated aromatase expression in inflamed breast tissue of obese women. (2012) (237)
- Symptom experience and quality of life of women following breast cancer treatment. (2007) (236)
- Tamoxifen, raloxifene, and the prevention of breast cancer. (1999) (234)
- The National Cancer Data Base 10‐year survey of breast carcinoma treatment at hospitals in the United States (1998) (229)
- Local therapy and survival in breast cancer. (2007) (227)
- Learning sentinel node biopsy: results of a prospective randomized trial of two techniques. (1999) (226)
- Factors influencing the use of breast reconstruction postmastectomy: a National Cancer Database study. (2001) (224)
- How Often Does Neoadjuvant Chemotherapy Avoid Axillary Dissection in Patients With Histologically Confirmed Nodal Metastases? Results of a Prospective Study (2016) (217)
- Locoregional treatment of primary breast cancer (2010) (206)
- Overview of Breast Cancer Therapy. (2018) (204)
- Hormone replacement therapy and risk of breast cancer with a favorable histology: results of the Iowa Women's Health Study. (1999) (198)
- What is an Adequate Margin for Breast-Conserving Surgery? Surgeon Attitudes and Correlates (2010) (197)
- Association of occult metastases in sentinel lymph nodes and bone marrow with survival among women with early-stage invasive breast cancer. (2011) (195)
- Quality of life among breast cancer patients with lymphedema: a systematic review of patient-reported outcome instruments and outcomes (2013) (192)
- Society of Surgical Oncology–American Society for Radiation Oncology–American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Ductal Carcinoma In Situ (2016) (190)
- Presenting Features of Breast Cancer Differ by Molecular Subtype (2009) (185)
- Nipple-Sparing Mastectomy for Breast Cancer and Risk-Reducing Surgery: The Memorial Sloan-Kettering Cancer Center Experience (2011) (184)
- Racial and ethnic disparities in the use of postmastectomy breast reconstruction: results from a population- based study. (2009) (181)
- Surgical margins in lumpectomy for breast cancer--bigger is not better. (2012) (180)
- Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update (2016) (180)
- Gaps in Incorporating Germline Genetic Testing Into Treatment Decision-Making for Early-Stage Breast Cancer. (2017) (179)
- Measuring Quality of Life in Oncologic Breast Surgery: A Systematic Review of Patient‐Reported Outcome Measures (2010) (179)
- Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021 (2021) (175)
- Breast cancer (2021) (174)
- Surgical issues in patients with breast cancer receiving neoadjuvant chemotherapy (2015) (173)
- Selective estrogen receptor modulation and reduction in risk of breast cancer, osteoporosis, and coronary heart disease. (2001) (172)
- Five-Year Outcomes After Prostatectomy or Radiotherapy for Prostate Cancer: The Prostate Cancer Outcomes Study (2006) (171)
- Decision involvement and receipt of mastectomy among racially and ethnically diverse breast cancer patients. (2009) (171)
- Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update. (2016) (171)
- ASCO/SSO Review of Current Role of Risk-Reducing Surgery in Common Hereditary Cancer Syndromes (2006) (171)
- Population-based study of the relationship of treatment and sociodemographics on quality of life for early stage breast cancer (2005) (169)
- Frequent Mutational Activation of the PI3K-AKT Pathway in Trastuzumab-Resistant Breast Cancer (2012) (166)
- Social and Clinical Determinants of Contralateral Prophylactic Mastectomy. (2014) (163)
- An informed decision? Breast cancer patients and their knowledge about treatment. (2006) (156)
- Axillary Nodal Management Following Neoadjuvant Chemotherapy: A Review (2017) (153)
- Breast-Conserving Treatment With or Without Radiotherapy in Ductal Carcinoma-In-Situ: Ten-Year Results of European Organisation for Research and Treatment of Cancer Randomized Phase III Trial 10853—A Study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group (2007) (151)
- Access to breast reconstruction after mastectomy and patient perspectives on reconstruction decision making. (2014) (147)
- Factors associated with patient involvement in surgical treatment decision making for breast cancer. (2007) (145)
- Systemic Correlates of White Adipose Tissue Inflammation in Early-Stage Breast Cancer (2015) (143)
- Chemoprevention of breast cancer: a model for change. (2002) (142)
- Patient-reported Quality of Life and Satisfaction With Cosmetic Outcomes After Breast Conservation and Mastectomy With and Without Reconstruction: Results of a Survey of Breast Cancer Survivors. (2015) (142)
- Standard for the Management of Ductal Carcinoma In Situ of the Breast (DCIS) (2002) (140)
- Lobular Carcinoma in Situ: A 29-Year Longitudinal Experience Evaluating Clinicopathologic Features and Breast Cancer Risk. (2015) (135)
- A Pilot Study of Preoperative Single-Dose Ipilimumab and/or Cryoablation in Women with Early-Stage Breast Cancer with Comprehensive Immune Profiling (2016) (135)
- Understanding the impact of breast reconstruction on the surgical decision‐making process for breast cancer (2008) (134)
- Meta-analysis of pre-operative magnetic resonance imaging (MRI) and surgical treatment for breast cancer (2017) (133)
- Correlates of referral practices of general surgeons to plastic surgeons for mastectomy reconstruction (2007) (127)
- Stage IV breast cancer in the era of targeted therapy (2010) (127)
- Society of Surgical Oncology: Position Statement on Prophylactic Mastectomy. Approved by the Society of Surgical Oncology Executive Council, March 2007 (2007) (126)
- Uptake, Results, and Outcomes of Germline Multiple-Gene Sequencing After Diagnosis of Breast Cancer (2018) (123)
- Clinical highlights from the National Cancer Data Base, 2000 (2000) (121)
- Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update. (2016) (120)
- Correlates of breast reconstruction (2005) (120)
- Medical contraindications are not a major factor in the underutilization of breast conserving therapy. (1998) (119)
- The Association of Surgical Margins and Local Recurrence in Women with Ductal Carcinoma In Situ Treated with Breast-Conserving Therapy: A Meta-Analysis (2016) (119)
- Toolbox to Reduce Lumpectomy Reoperations and Improve Cosmetic Outcome in Breast Cancer Patients: The American Society of Breast Surgeons Consensus Conference (2015) (116)
- Bilateral Mastectomy versus Breast-Conserving Surgery for Early-Stage Breast Cancer: The Role of Breast Reconstruction (2015) (113)
- Sentinel Node Skills Verification and Surgeon Performance: Data From a Multicenter Clinical Trial for Early-Stage Breast Cancer (2005) (113)
- The woman at increased risk for breast cancer: Evaluation andmanagement strategies (1995) (113)
- Breast-Conserving Therapy Achieves Locoregional Outcomes Comparable to Mastectomy in Women with T1-2N0 Triple-Negative Breast Cancer (2013) (112)
- ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes. (2006) (112)
- Skin Flap Necrosis After Mastectomy With Reconstruction: A Prospective Study (2015) (111)
- The evaluation of common breast problems. (2000) (109)
- Deep Sequencing of T-cell Receptor DNA as a Biomarker of Clonally Expanded TILs in Breast Cancer after Immunotherapy (2016) (109)
- Contralateral Prophylactic Mastectomy Decisions in a Population-Based Sample of Patients With Early-Stage Breast Cancer (2016) (109)
- Metabolic Obesity, Adipose Inflammation and Elevated Breast Aromatase in Women with Normal Body Mass Index (2017) (107)
- Surgical aspects of inflammatory breast cancer. (2005) (107)
- Genetic Testing and Counseling Among Patients With Newly Diagnosed Breast Cancer (2017) (104)
- Axillary Dissection Can Be Avoided in the Majority of Clinically Node-Negative Patients Undergoing Breast-Conserving Therapy (2013) (103)
- American society of clinical oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction. (2009) (103)
- ACOSOG Z0011: A randomized trial of axillary node dissection in women with clinical T1-2 N0 M0 breast cancer who have a positive sentinel node. (2010) (99)
- The Effect of Multiple Reexcisions on the Risk of Local Recurrence After Breast Conserving Surgery (2007) (98)
- Current management of lesions associated with an increased risk of breast cancer (2015) (97)
- Trends in Reoperation After Initial Lumpectomy for Breast Cancer: Addressing Overtreatment in Surgical Management (2017) (96)
- Stereotactic core‐needle biopsy of the breast: A report of the Joint Task Force of the American College of Radiology, American College of Surgeons, and College of American Pathologists (1997) (95)
- Patterns and correlates of local therapy for women with ductal carcinoma-in-situ. (2005) (94)
- Is Low-Volume Disease in the Sentinel Node After Neoadjuvant Chemotherapy an Indication for Axillary Dissection? (2018) (93)
- Ductal lavage findings in women with known breast cancer undergoing mastectomy. (2004) (91)
- The 2014 Society of Surgical Oncology Susan G. Komen for the Cure Symposium: Triple-Negative Breast Cancer (2015) (91)
- Outcome of axillary staging in early breast cancer: a meta-analysis (2010) (90)
- Relationship Between Margin Width and Recurrence of Ductal Carcinoma In Situ: Analysis of 2996 Women Treated With Breast-conserving Surgery for 30 Years. (2015) (90)
- Radioactive Seed Localization Compared to Wire Localization in Breast-Conserving Surgery: Initial 6-Month Experience (2013) (90)
- Changes in breast cancer therapy because of pathology second opinions (2002) (89)
- Factors Associated With Local-Regional Recurrence After a Negative Sentinel Node Dissection: Results of the ACOSOG Z0010 Trial (2012) (89)
- Compliance with breast‐conservation standards for patients with early‐stage breast carcinoma (2003) (89)
- Postmastectomy chest wall radiation to a temporary tissue expander or permanent breast implant--is there a difference in complication rates? (2007) (88)
- Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Ductal Carcinoma in Situ. (2016) (88)
- Should clinicians be concerned about the carcinogenic potential of tamoxifen? (1994) (87)
- American Society of Clinical Oncology Clinical Practice Guideline Update on the Use of Pharmacologic Interventions Including Tamoxifen, Raloxifene, and Aromatase Inhibition for Breast Cancer Risk Reduction. (2009) (86)
- Axillary Dissection and Nodal Irradiation Can Be Avoided for Most Node-positive Z0011-eligible Breast Cancers: A Prospective Validation Study of 793 Patients (2017) (85)
- Patterns and correlates of adjuvant radiotherapy receipt after lumpectomy and after mastectomy for breast cancer. (2010) (85)
- Does clearing of axillary lymph nodes contribute to accurate staging of breast carcinoma? (1984) (83)
- Four-week course of radiation for breast cancer using hypofractionated intensity modulated radiation therapy with an incorporated boost. (2007) (83)
- Menopause Is a Determinant of Breast Adipose Inflammation (2015) (82)
- Concerns about cancer risk and experiences with genetic testing in a diverse population of patients with breast cancer. (2015) (82)
- Retrospective Analysis of 18F-FDG PET/CT for Staging Asymptomatic Breast Cancer Patients Younger Than 40 Years (2014) (80)
- Contralateral prophylactic mastectomy for breast cancer: addressing peace of mind. (2013) (80)
- Correlates of Between-Surgeon Variation in Breast Cancer Treatments (2006) (80)
- Long-Term Patient-Reported Satisfaction after Contralateral Prophylactic Mastectomy and Implant Reconstruction (2013) (79)
- Comparison of Conventional Surgical Resection, Radioactive Implantation, and Bypass Procedures for Exocrine Carcinoma of the Pancreas 1975–1980 (1984) (79)
- Morbidity of Sentinel Node Biopsy in Breast Cancer: The Relationship Between the Number of Excised Lymph Nodes and Lymphedema (2010) (78)
- The Extent of Extracapsular Extension May Influence the Need for Axillary Lymph Node Dissection in Patients with T1–T2 Breast Cancer (2014) (77)
- Secondary Surgical Cytoreduction for Advanced Ovarian Carcinoma (2006) (74)
- MRI and Prediction of Pathologic Complete Response in the Breast and Axilla after Neoadjuvant Chemotherapy for Breast Cancer. (2017) (74)
- Lobular carcinoma in situ: current concepts and controversies. (1999) (74)
- Margins in breast cancer: How much is enough? (2018) (73)
- Does a Positive Axillary Lymph Node Needle Biopsy Result Predict the Need for an Axillary Lymph Node Dissection in Clinically Node-Negative Breast Cancer Patients in the ACOSOG Z0011 Era? (2016) (73)
- Characteristics of salivary profiles of oestradiol and progesterone in premenopausal women. (2005) (73)
- Rational local therapy for breast cancer. (2002) (72)
- Breast intraductal papillomas without atypia in radiologic‐pathologic concordant core‐needle biopsies: Rate of upgrade to carcinoma at excision (2016) (71)
- Comparison of 18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Invasive Lobular Carcinoma Versus Invasive Ductal Carcinoma (2015) (68)
- Should ACOSOG Z0011 change practice with respect to axillary lymph node dissection for a positive sentinel lymph node biopsy in breast cancer? (2012) (68)
- Favorable prognosis in patients with T1a/T1bN0 triple‐negative breast cancers treated with multimodality therapy (2012) (68)
- More mastectomies: is this what patients really want? (2009) (68)
- Estrogen Receptor, Progesterone Receptor, and HER2 Status Predict Lymphovascular Invasion and Lymph Node Involvement (2014) (67)
- Magnetic resonance imaging in the breast cancer patient: curb your enthusiasm. (2008) (67)
- Appearance of untreated bone metastases from breast cancer on FDG PET/CT: importance of histologic subtype (2015) (66)
- Menopause Is a Determinant of Breast Aromatase Expression and Its Associations With BMI, Inflammation, and Systemic Markers (2017) (66)
- Feasibility and Predictability of Perioperative PET and Estrogen Receptor Ligand in Patients with Invasive Breast Cancer (2013) (64)
- αB-crystallin is a novel predictor of resistance to neoadjuvant chemotherapy in breast cancer (2008) (63)
- Prospective Comparison of Stereotactic Core Biopsy and Surgical Excision as Diagnostic Procedures for Breast Cancer Patients (2001) (63)
- Is Preoperative Axillary Imaging Beneficial in Identifying Clinically Node-Negative Patients Requiring Axillary Lymph Node Dissection? (2016) (62)
- A Comparison of Patient-Reported Outcomes After Nipple-Sparing Mastectomy and Conventional Mastectomy with Reconstruction (2018) (62)
- Receipt of Delayed Breast Reconstruction After Mastectomy: Do Women Revisit the Decision? (2011) (61)
- Presence of Lobular Carcinoma In Situ Does Not Increase Local Recurrence in Patients Treated with Breast-Conserving Therapy (2008) (61)
- Do LORIS Trial Eligibility Criteria Identify a Ductal Carcinoma In Situ Patient Population at Low Risk of Upgrade to Invasive Carcinoma? (2016) (60)
- Patient satisfaction with treatment of breast cancer: does surgeon specialization matter? (2007) (60)
- A Comparison of Ductoscopy-Guided and Conventional Surgical Excision in Women With Spontaneous Nipple Discharge (2005) (59)
- Diet and the risk of salivary gland cancer. (1997) (59)
- Treatment‐associated toxicities reported by patients with early‐stage invasive breast cancer (2017) (57)
- A prospective analysis of surgery and survival in stage IV breast cancer (TBCRC 013). (2016) (57)
- Magnetic resonance imaging in breast cancer: one step forward, two steps back? (2004) (56)
- Surgeon Attitudes Toward the Omission of Axillary Dissection in Early Breast Cancer (2018) (55)
- Surgeon perspectives about local therapy for breast carcinoma (2005) (55)
- Society of Surgical Oncology Breast Disease Working Group Statement on Prophylactic (Risk-Reducing) Mastectomy (2017) (55)
- National Cancer Data Base survey of breast cancer management for patients from low income zip codes (2000) (55)
- ACOSOG Z0010: A multicenter prognostic study of sentinel node (SN) and bone marrow (BM) micrometastases in women with clinical T1/T2 N0 M0 breast cancer. (2010) (55)
- Patient selection for breast conservation therapy with magnification mammography. (1995) (55)
- Cost minimization study of image-guided core biopsy versus surgical excisional biopsy for women with abnormal mammograms. (2004) (55)
- A 10-Year Trend Analysis of Sentinel Lymph Node Frozen Section and Completion Axillary Dissection for Breast Cancer: Are These Procedures Becoming Obsolete? (2011) (55)
- Recurrence risk perception and quality of life following treatment of breast cancer (2017) (55)
- Current comprehensive assessment and management of women at increased risk for breast cancer. (2004) (54)
- Characteristics and Outcomes of Sentinel Node–Positive Breast Cancer Patients after Total Mastectomy without Axillary-Specific Treatment (2012) (54)
- A clinical oncology perspective on the use of breast MR. (2006) (53)
- Early Adoption of the SSO-ASTRO Consensus Guidelines on Margins for Breast-Conserving Surgery with Whole-Breast Irradiation in Stage I and II Invasive Breast Cancer: Initial Experience from Memorial Sloan Kettering Cancer Center (2016) (53)
- Breast disease in elderly women. (1994) (53)
- Gaps in Receipt of Clinically Indicated Genetic Counseling After Diagnosis of Breast Cancer. (2018) (52)
- Treatment decisions and employment of breast cancer patients: Results of a population‐based survey (2017) (52)
- Decreasing Recurrence Rates for Ductal Carcinoma In Situ: Analysis of 2996 Women Treated with Breast-Conserving Surgery Over 30 Years (2015) (51)
- Impact of the SSO-ASTRO Margin Guideline on Rates of Re-excision After Lumpectomy for Breast Cancer: A Meta-analysis (2019) (51)
- Perioperative Breast MRI Is Not Associated with Lower Locoregional Recurrence Rates in DCIS Patients Treated With or Without Radiation (2014) (51)
- Local control following breast-conserving surgery for invasive cancer: results of clinical trials. (1995) (51)
- Prognostic Impact of 21-Gene Recurrence Score in Patients With Stage IV Breast Cancer: TBCRC 013. (2016) (51)
- Surgery of the primary tumor in metastatic breast cancer: closing the barn door after the horse has bolted? (2006) (50)
- The Influence of Age on the Breast Surgery Decision-Making Process (2008) (50)
- Evaluation of common breast problems: Guidance for primary care providers (1998) (50)
- Results of hospital cancer registry surveys by the American College of Surgeons (1997) (49)
- Morbidity of Sentinel Node Biopsy: Relationship Between Number of Excised Lymph Nodes and Patient Perceptions of Lymphedema (2011) (49)
- Leptin regulation of the p53-HIF1α/PKM2-aromatase axis in breast adipose stromal cells – a novel mechanism for the obesity-breast cancer link (2017) (49)
- Do Calcifications Seen on Mammography After Neoadjuvant Chemotherapy for Breast Cancer Always Need to Be Excised? (2017) (48)
- To Cut Is to Cure: Can We Really Apply Z11 in Practice? (2011) (48)
- Cadherin–catenin complex dissociation in lobular neoplasia of the breast (2012) (48)
- A Comparison of Patient-Reported Outcomes After Breast-Conserving Surgery and Mastectomy with Implant Breast Reconstruction (2019) (48)
- Effect of Margin Width on Local Recurrence in Triple-Negative Breast Cancer Patients Treated with Breast-Conserving Therapy (2014) (48)
- Role of axillary dissection in breast cancer management (1996) (47)
- Selecting patients for breast‐conserving therapy (2006) (47)
- The Effect of Molecular Subtype and Residual Disease on Locoregional Recurrence in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy and Postmastectomy Radiation (2015) (47)
- Patterns and correlates of patient referral to surgeons for treatment of breast cancer. (2007) (47)
- Is there a role for routine screening MRI in women with LCIS? (2013) (47)
- Breast conservation and negative margins: how much is enough? (2009) (46)
- Ductal lavage and ductoscopy: the opportunities and the limitations. (2002) (46)
- Results of the Lynn Sage Second‐Opinion Program for local therapy in patients with breast carcinoma (2002) (45)
- Factors that influence surgical choices in women with breast carcinoma (2002) (45)
- Menstrual and reproductive factors for salivary gland cancer risk in women. (1999) (45)
- Prediction of breast cancer size by ultrasound, mammography and core biopsy. (2004) (44)
- Standard Pathologic Features Can Be Used to Identify a Subset of Estrogen Receptor-Positive, HER2 Negative Patients Likely to Benefit from Neoadjuvant Chemotherapy (2017) (44)
- Five-year local control in a phase II study of hypofractionated intensity modulated radiation therapy with an incorporated boost for early stage breast cancer. (2012) (43)
- The Optimal Treatment Plan to Avoid Axillary Lymph Node Dissection in Early-Stage Breast Cancer Patients Differs by Surgical Strategy and Tumor Subtype (2017) (43)
- Clonal relatedness between lobular carcinoma in situ and synchronous malignant lesions (2012) (42)
- Tumor Biology Predicts Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients Presenting with Locally Advanced Breast Cancer (2017) (41)
- Factors influencing outcomes for breast conservation therapy of mammographically detected malignancies. (2003) (41)
- Radioactive Seed Localization With 125I For Nonpalpable Lesions Prior to Breast Lumpectomy and/or Excisional Biopsy: Methodology, Safety, and Experience of Initial Year (2013) (41)
- Molecular mechanisms of resistance to tamoxifen therapy in breast cancer. (1993) (40)
- Selecting Node-Positive Patients for Axillary Downstaging with Neoadjuvant Chemotherapy (2020) (40)
- Surgeon Influence on Variation in Receipt of Contralateral Prophylactic Mastectomy for Women With Breast Cancer (2017) (39)
- Axillary dissection: when and how radical? (1996) (39)
- Impact of Age on Risk of Recurrence of Ductal Carcinoma In Situ: Outcomes of 2996 Women Treated with Breast-Conserving Surgery Over 30 Years (2016) (39)
- Personalizing extent of breast cancer surgery according to molecular subtypes. (2013) (39)
- Increase in Utilization of Nipple-Sparing Mastectomy for Breast Cancer: Indications, Complications, and Oncologic Outcomes (2019) (39)
- Evaluation of Local and Distant Recurrence Patterns in Patients with Triple-Negative Breast Cancer According to Age (2017) (39)
- Impact of Breast Density on the Presenting Features of Malignancy (2010) (38)
- Practice guideline for the breast conservation therapy in the management of invasive breast carcinoma. (2007) (38)
- Breast cancer surgery trends and outcomes: results from a National Department of Veterans Affairs study. (2004) (37)
- Does It Matter Where You Go for Breast Surgery?: Attending Surgeon's Influence on Variation in Receipt of Mastectomy for Breast Cancer (2010) (37)
- Management of the axillary nodes (1999) (37)
- Margins in breast conservation: A clinician's perspective and what the literature tells us (2014) (37)
- A prospective study of variability in mammographic density during the menstrual cycle (2010) (37)
- Purposes and principles of staging. (1992) (37)
- Magnetic resonance imaging in the preoperative evaluation of breast cancer: primum non nocere. (2004) (37)
- Addressing overtreatment in breast cancer (2013) (37)
- The challenge of developing quality measures for breast cancer surgery. (2012) (37)
- Margins in breast-conserving therapy: have we lost sight of the big picture? (2008) (36)
- Pre-cancerous breast lesions: implications for breast cancer prevention trials. (1992) (35)
- Acceptance of tamoxifen chemoprevention by physicians and women at risk (2004) (35)
- How Often Does Modern Neoadjuvant Chemotherapy Downstage Patients to Breast-Conserving Surgery? (2020) (35)
- Ductal carcinoma in situ--current management. (2007) (35)
- Prophylactic mastectomy of the contralateral breast. (2011) (35)
- Improving Breast Cancer Surgical Treatment Decision Making: The iCanDecide Randomized Clinical Trial. (2018) (34)
- Evaluation and management of the woman with an abnormal ductal lavage. (2002) (34)
- Extent of Microinvasion in Ductal Carcinoma In Situ is not Associated with Sentinel Lymph Node Metastases (2014) (34)
- Why Are There So Many Mastectomies in the United States? (2017) (34)
- Treatment Decision Making and Genetic Testing for Breast Cancer: Mainstreaming Mutations. (2015) (33)
- Axillary Micrometastases and Isolated Tumor Cells Are Not an Indication for Post-mastectomy Radiotherapy in Stage 1 and 2 Breast Cancer (2017) (33)
- The challenge of individualizing treatments for patients with breast cancer. (2012) (33)
- alphaB-crystallin is a novel predictor of resistance to neoadjuvant chemotherapy in breast cancer. (2008) (32)
- Most Breast Cancer Patients with T1-2 Tumors and One to Three Positive Lymph Nodes Do Not Need Postmastectomy Radiotherapy (2018) (32)
- AACR Cancer Progress Report 2016 (2016) (32)
- HORMONE REPLACEMENT THERAPY AND RISK OF BREAST CANCER WITH A FAVORABLE HISTOLOGY : RESULTS OF THE IOWA WOMEN'S HEALTH STUDY (1999) (32)
- Contralateral breast cancers: Independent cancers or metastases? (2018) (32)
- Time Trends in Receipt of Germline Genetic Testing and Results for Women Diagnosed With Breast Cancer or Ovarian Cancer, 2012-2019. (2021) (31)
- The need for lymph node dissection in nonmetastatic breast cancer. (2013) (31)
- Gene expression profiling of lobular carcinoma in situ reveals candidate precursor genes for invasion (2015) (31)
- The Effect of Adjuvant Trastuzumab on Locoregional Recurrence of Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Treated with Mastectomy (2015) (31)
- A Survival Benefit From Axillary Dissection: Was Halsted Correct? (1999) (30)
- Pathologic complete response rate according to HER2 detection methods in HER2-positive breast cancer treated with neoadjuvant systemic therapy (2019) (30)
- MRI-based machine learning radiomics can predict HER2 expression level and pathologic response after neoadjuvant therapy in HER2 overexpressing breast cancer (2020) (30)
- Occult Malignancy in Patients Undergoing Contralateral Prophylactic Mastectomy (2011) (30)
- Nodal Irradiation after Breast-Cancer Surgery in the Era of Effective Adjuvant Therapy. (2015) (30)
- MRI and breast cancer: role in detection, diagnosis, and staging. (2007) (30)
- Surgical management of the axilla: do intramammary nodes matter? (2009) (30)
- Impact of Margin Assessment Method on Positive Margin Rate and Total Volume Excised (2013) (30)
- Expression of Epithelial Mucins MUC1, MUC2, and MUC3 in Ductal Carcinoma In Situ of the Breast (2001) (30)
- Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study population (2017) (30)
- Patient Reactions to Surgeon Recommendations About Contralateral Prophylactic Mastectomy for Treatment of Breast Cancer (2017) (30)
- Breast Disease (2019) (30)
- COX-2 and PPARγ expression are potential markers of recurrence risk in mammary duct carcinoma in-situ (2008) (30)
- Correction to: De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 (Annals of Oncology (2017) 28(8) (1700–1712), (S0923753419321817), (10.1093/annonc/mdx308)) (2017) (29)
- How Often Is Treatment Effect Identified in Axillary Nodes with a Pathologic Complete Response After Neoadjuvant Chemotherapy? (2016) (29)
- Status of postmastectomy radiotherapy in the United States: a patterns of care study. (2004) (29)
- 21-Gene recurrence score and locoregional recurrence in lymph node-negative, estrogen receptor-positive breast cancer (2017) (29)
- How Effective is Neoadjuvant Endocrine Therapy (NET) in Downstaging the Axilla and Achieving Breast-Conserving Surgery? (2020) (29)
- Limiting breast surgery to the proper minimum. (2005) (29)
- Final results of a phase II trial of preoperative TAC (docetaxel/doxorubicin/cyclophosphamide) in stage III breast cancer. (2005) (29)
- Ductal carcinoma in situ. (2003) (29)
- Prophylactic mastectomy and the timing of breast reconstruction (2009) (28)
- Effect of reexcision on the success of breast-conserving surgery (1995) (28)
- Sometimes a great notion--an assessment of neoadjuvant systemic therapy for breast cancer. (2005) (28)
- The association of surgical margins and local recurrence in women with ductal carcinoma in situ treated with breast-conserving therapy: A meta-analysis. (2016) (28)
- Radiation field design and regional control in sentinel lymph node‐positive breast cancer patients with omission of axillary dissection (2012) (28)
- A Feasibility Study of Bevacizumab plus Dose-Dense Doxorubicin–Cyclophosphamide (AC) Followed by Nanoparticle Albumin–Bound Paclitaxel in Early-Stage Breast Cancer (2011) (28)
- Breast conservation for mammographically occult carcinoma. (1998) (27)
- Raloxifene as a multifunctional medicine? (1999) (27)
- Coordinating Cancer Care: Patient and Practice Management Processes Among Surgeons Who Treat Breast Cancer (2010) (27)
- Association of Germline Genetic Testing Results With Locoregional and Systemic Therapy in Patients With Breast Cancer. (2020) (27)
- Troubleshooting Sentinel Lymph Node Biopsy in Breast Cancer Surgery (2016) (27)
- Diffuse cystic angiomatosis of the breast (1988) (26)
- Do MRI and Mammography Reliably Identify Candidates for Breast Conservation After Neoadjuvant Chemotherapy? (2015) (26)
- Age and Receptor Status Do Not Indicate the Need for Axillary Dissection in Patients with Sentinel Lymph Node Metastases (2016) (26)
- Effect of Time Interval on Residual Disease in Breast Cancer (2003) (26)
- Nodal Recurrence in Patients With Node-Positive Breast Cancer Treated With Sentinel Node Biopsy Alone After Neoadjuvant Chemotherapy-A Rare Event. (2021) (26)
- FGFR1 underlies obesity-associated progression of estrogen receptor-positive breast cancer after estrogen deprivation. (2018) (26)
- Intraoperative opioids are associated with improved recurrence-free survival in triple-negative breast cancer. (2020) (26)
- Modified radical mastectomy with knife technique. (2002) (26)
- Magnetic resonance imaging for screening, diagnosis, and eligibility for breast-conserving surgery: promises and pitfalls. (2010) (26)
- Reoperative Sentinel Lymph Node Biopsy is Feasible for Locally Recurrent Breast Cancer, But is it Worthwhile? (2016) (25)
- Patients with a history of epithelial ovarian cancer presenting with a breast and/or axillary mass. (2009) (25)
- Knowledge gaps in oncoplastic breast surgery. (2020) (25)
- Association of Attending Surgeon With Variation in the Receipt of Genetic Testing After Diagnosis of Breast Cancer (2018) (25)
- Contralateral Breast Cancer Risk in Women with Ductal Carcinoma In Situ: Is it High Enough to Justify Bilateral Mastectomy? (2017) (25)
- Randomized Trial Comparing Axillary Clearance Versus No Axillary Clearance in Older Patients With Breast Cancer: First Results of International Breast Cancer Study Group Trial 10–93 (2007) (25)
- The Evolving Role of Partial Breast Irradiation in Early-Stage Breast Cancer (2013) (25)
- Long-Term Outcomes After Surgical Treatment of Malignant/Borderline Phyllodes Tumors of the Breast (2019) (25)
- Results of Hospital Cancer Registry Surveys by the American College of Surgeons. Outcomes of Prostate Cancer Treatment by Radical Prostatectomy (1998) (25)
- The evolution of the locoregional therapy of breast cancer. (2011) (25)
- The certainties and the uncertainties of ductal carcinoma in situ. (2004) (24)
- Chemoprevention Uptake for Breast Cancer Risk Reduction Varies by Risk Factor (2019) (24)
- Management of the Node-Positive Axilla in Breast Cancer in 2017: Selecting the Right Option. (2017) (24)
- Coordination of breast cancer care between radiation oncologists and surgeons: a survey study. (2010) (24)
- The 21-gene recurrence score in special histologic subtypes of breast cancer with favorable prognosis (2017) (24)
- Radiation Therapy After Breast-Conserving Surgery in Women 70 Years of Age and Older: How Wisely Do We Choose? (2019) (23)
- Pathologic Complete Response with Neoadjuvant Doxorubicin and Cyclophosphamide Followed by Paclitaxel with Trastuzumab and Pertuzumab in Patients with HER2-Positive Early Stage Breast Cancer: A Single Center Experience. (2017) (23)
- Breast Cancers of Special Histologic Subtypes Are Biologically Diverse (2018) (23)
- Number of lymph nodes removed in sentinel lymph node‐negative breast cancer patients is significantly related to patient age and tumor size (2010) (23)
- Does race predict survival for women with invasive breast cancer? (2019) (23)
- The association between patient attitudes and values and the strength of consideration for contralateral prophylactic mastectomy in a population‐based sample of breast cancer patients (2017) (22)
- Treatment decisions and employment of breast cancer patients: Results of a population-based survey. (2017) (22)
- Management of axillary lymph nodes in breast cancer: a national patterns of care study of 17,151 patients. (1999) (22)
- The Society of Surgical Oncology-American Society for Radiation Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stages I and II Invasive Breast Cancer: Perspectives for Pathologists. (2015) (22)
- Black race as a prognostic factor in triple-negative breast cancer patients treated with breast-conserving therapy: a large, single-institution retrospective analysis (2013) (22)
- Combined hormone therapy and breast cancer: a single-edged sword. (2003) (22)
- Survival Outcomes for Metaplastic Breast Cancer Differ by Histologic Subtype (2021) (22)
- A clinical oncologic perspective on breast magnetic resonance imaging. (2010) (22)
- Patterns and Predictors of Mammography Utilization Among Breast Cancer Survivors (2007) (21)
- Risk factors and the prevention of breast cancer with tamoxifen. (1993) (21)
- Reducing Overtreatment of Cancer With Precision Medicine: Just What the Doctor Ordered. (2018) (21)
- Bilateral implant reconstruction does not affect the quality of postmastectomy radiation therapy. (2014) (21)
- Trends in the Surgical Treatment of Breast Cancer (2010) (21)
- Addressing Overtreatment in DCIS: What Should Physicians Do Now? (2015) (21)
- Impact of Age on Locoregional and Distant Recurrence After Mastectomy for Ductal Carcinoma In Situ With or Without Microinvasion (2019) (20)
- Incidental Breast Lesions Identified by 18F-Fluorodeoxyglucose-Positron Emission Tomography (2010) (20)
- A pilot study of preoperative (Pre-op), single-dose ipilimumab (Ipi) and/or cryoablation (Cryo) in women (pts) with early-stage/resectable breast cancer (ESBC). (2013) (20)
- Changes in Reoperation After Publication of Consensus Guidelines on Margins for Breast-Conserving Surgery: A Systematic Review and Meta-analysis. (2020) (20)
- Lymph Node Status in Breast Cancer Does Not Predict Tumor Biology (2018) (20)
- Ductal Lavage Findings in Women With Mammographic Microcalcifications Undergoing Biopsy (2004) (20)
- Postmastectomy radiotherapy for breast cancer (2009) (20)
- Pre-operative breast MRI in women with recently diagnosed breast cancer--where to next? (2010) (19)
- Is There a Low-Grade Precursor Pathway in Breast Cancer? (2012) (19)
- Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stages I and II Invasive Breast Cancer (2014) (19)
- Poor response to neoadjuvant chemotherapy in metaplastic breast carcinoma (2021) (19)
- Is axillary dissection necessary after positive sentinel node biopsy? Yes! (2001) (19)
- Locoregional Management After Neoadjuvant Chemotherapy. (2020) (19)
- The natural history of ductal carcinoma in situ. Implications for clinical decision making (1995) (19)
- Comparison of Local Recurrence Risk Estimates After Breast-Conserving Surgery for DCIS: DCIS Nomogram Versus Refined Oncotype DX Breast DCIS Score (2019) (19)
- Management of ductal carcinoma in situ (1995) (19)
- Predictors of Completion Axillary Lymph Node Dissection in Patients With Immunohistochemical Metastases to the Sentinel Lymph Node in Breast Cancer (2010) (18)
- Minimally invasive surgery for breast cancer (2009) (18)
- Management of the clinically node-negative axilla: what have we learned from the clinical trials? (2014) (18)
- Breast cancer. Making the diagnosis. (1999) (18)
- Conflicts in Decision-Making for Breast Cancer Surgery (2007) (18)
- Impact of Body Mass Index on Clinical Axillary Nodal Assessment in Breast Cancer Patients (2016) (18)
- Is Clinical Exam of the Axilla Sufficient to Select Node-Positive Patients Who Downstage After NAC for SLNB? A Comparison of the Accuracy of Clinical Exam Versus MRI (2019) (18)
- Are there patients with T1 to T2, lymph node‐negative breast cancer who are “high‐risk” for locoregional disease recurrence? (2017) (18)
- Should intraoperative frozen section evaluation of breast lumpectomy margins become routine practice? (2012) (18)
- CLINICAL DECISIONS. Ductal Carcinoma In Situ. (2016) (18)
- Oncologic Outcomes After Treatment for MRI Occult Breast Cancer (pT0N+) (2017) (18)
- An adequate margin of excision in ductal carcinoma in situ (2005) (17)
- Evaluation of breast tissue with confocal strip-mosaicking microscopy: a test approach emulating pathology-like examination (2017) (17)
- Prostaglandin E2 down-regulates sirtuin 1 (SIRT1), leading to elevated levels of aromatase, providing insights into the obesity–breast cancer connection (2018) (17)
- De-escalating Breast Cancer Surgery-Where Is the Tipping Point? (2019) (16)
- Sentinel Node Biopsy After Neoadjuvant Chemotherapy in Breast Cancer: Results From National Surgical Adjuvant Breast and Bowel Project Protocol B-27 (2006) (16)
- The dilemma of DCIS. (2007) (16)
- Tamoxifen use in patients with ductal carcinoma in situ and T1a/b N0 invasive carcinoma. (2005) (16)
- Breast carcinoma with an Oncotype Dx recurrence score <18: Rate of distant metastases in a large series with clinical follow‐up (2017) (16)
- Microscopic Extracapsular Extension in Sentinel Lymph Nodes Does Not Mandate Axillary Dissection in Z0011-Eligible Patients (2019) (16)
- Patterns and Correlates of Knowledge, Communication, and Receipt of Breast Reconstruction in a Modern Population-Based Cohort of Patients with Breast Cancer. (2019) (16)
- Verapamil enhances antitumor activity without increasing myeloid toxicity. (1987) (16)
- Who should not receive chemotherapy? Data from American databases and trials. (2001) (16)
- Treatment selection in ductal carcinoma in situ. (2000) (15)
- Metastatic Colorectal Carcinoma: Cost-Effectiveness of Percutaneous Radiofrequency Ablation Versus That of Hepatic Resection (2006) (15)
- Identification of the woman at risk for breast cancer: problem solved? (1999) (15)
- Should Breast Density Influence Patient Selection for Breast-Conserving Surgery? (2013) (15)
- Margins in ductal carcinoma in situ: is bigger really better? (2012) (15)
- Breast-Conserving Surgery in Bilateral Breast Cancer (2015) (15)
- Noninvasive Detection of Inflammatory Changes in White Adipose Tissue by Label-Free Raman Spectroscopy. (2016) (14)
- Outcomes for Women with Minimal-Volume Ductal Carcinoma In Situ Completely Excised at Core Biopsy (2017) (14)
- Current controversies in breast cancer management. (1999) (14)
- Patient views and correlates of radiotherapy omission in a population‐based sample of older women with favorable‐prognosis breast cancer (2018) (14)
- A 47-year-old woman with ductal carcinoma in situ. (1996) (14)
- Diseases of the breast: Fifth edition (2014) (14)
- Understanding ductal carcinoma in situ (1999) (13)
- The 21-Gene Recurrence Score in Male Breast Cancer (2018) (13)
- Appropriate margin for lumpectomy excision of invasive breast cancer. (2016) (13)
- Post-Mastectomy Breast Reconstruction: Exploring Plastic Surgeon Practice Patterns and Perspectives. (2020) (13)
- Should routine breast cancer staging include MRI? (2009) (13)
- Axillary Dissection: An Obsolete Operation? (1998) (13)
- An appraisal of strategies to reduce the incidence of breast cancer (1993) (13)
- Ten-year survival results of ACOSOG Z0011: A randomized trial of axillary node dissection in women with clinical T1-2 N0 M0 breast cancer who have a positive sentinel node (Alliance). (2016) (13)
- Sentinel node biopsy after neoadjuvant chemotherapy: a new standard for patients with axillary metastases? (2013) (13)
- Dermal Lymphatic Invasion and Inflammatory Breast Cancer Are Independent Predictors of Outcome After Postmastectomy Radiation (2009) (12)
- Time for a new era in outcomes reporting for breast reconstruction. (2011) (12)
- Development and Validation of the BREAST-Q Breast-Conserving Therapy Module (2020) (12)
- Refining the use of endocrine therapy for ductal carcinoma in situ. (2012) (12)
- Applications for breast magnetic resonance imaging. (2014) (12)
- Current Status of Axillary Node Dissection (1999) (12)
- Is Routine Axillary Imaging Necessary in Clinically Node-Negative Patients Undergoing Neoadjuvant Chemotherapy? (2017) (12)
- Society of Surgical OncologyeAmerican Society for Radiation Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stages I and II Invasive Breast Cancer (2015) (12)
- Late Axillary Recurrence After Negative Sentinel Lymph Node Biopsy is Uncommon (2016) (12)
- Identification and management of the woman at increased risk for breast cancer development (2004) (12)
- Abstract P2-18-09: TBCRC 013: A prospective analysis of the role of surgery in stage IV breast cancer (2013) (12)
- Clinical dilemma of ductal carcinoma in situ. (2009) (12)
- Individualizing Surveillance Mammography for Older Patients After Treatment for Early-Stage Breast Cancer: Multidisciplinary Expert Panel and International Society of Geriatric Oncology Consensus Statement. (2021) (12)
- De-escalating and escalating surgery in the management of early breast cancer. (2017) (11)
- Do the ACOSOG Z0011 Criteria Affect the Number of Sentinel Lymph Nodes Removed? (2015) (11)
- Accuracy of Intraoperative Frozen Section of Sentinel Lymph Nodes After Neoadjuvant Chemotherapy for Breast Carcinoma (2019) (11)
- It is not always necessary to do axillary dissection for T1 and T2 breast cancer--point. (2013) (11)
- Contralateral prophylactic mastectomy in breast cancer: what to discuss with patients (2020) (11)
- Magnetic resonance imaging in breast cancer: is seeing always believing? (2005) (11)
- Rethinking the Local Therapy of Breast Cancer: Integration of Biology and Anatomy (2015) (11)
- Postmastectomy Breast Reconstruction: Exploring Plastic Surgeon Practice Patterns and Perspectives. (2020) (11)
- Breast-conserving surgery in the neoadjuvant setting. (1998) (11)
- Differentially expressed genes in window trials are influenced by the wound-healing process: lessons learned from a pilot study with anastrozole. (2012) (11)
- Patient Experiences and Clinician Views on the Role of Radiation Therapy for Ductal Carcinoma In Situ. (2018) (11)
- Differences in degree of lesion enhancement on CEM between ILC and IDC (2019) (10)
- Changing the Default: A Prospective Study of Reducing Discharge Opioid Prescription after Lumpectomy and Sentinel Node Biopsy (2020) (10)
- Intraoperative Ketorolac is Associated with Risk of Reoperation After Mastectomy: A Single-Center Examination (2021) (10)
- Correlates of contralateral prophylactic mastectomy in a population-based sample. (2011) (10)
- Does nonmetastatic inflammatory breast cancer have a worse prognosis than other nonmetastatic T4 cancers? (2018) (10)
- Flat Epithelial Atypia in Breast Core Needle Biopsies With Radiologic-Pathologic Concordance (2019) (10)
- The clinical impact and outcomes of immunohistochemistry-only metastasis in breast cancer. (2010) (10)
- History of Smoking is Associated with Younger Age at Diagnosis of Breast Cancer (2010) (10)
- Selecting Patients for Breast-Conserving Therapy: The Importance of Lobular HistologyMorrow M, Keeney K, Scholtens D, et al (Fox Chase Cancer Ctr, Philadelphia; Northwestern Univ, Chicago) Cancer 106:2563–2568, 2006§ (2007) (10)
- Why do women get mastectomy? Results from a population-based study (2007) (10)
- Managing Breast Cancer Risk (2003) (10)
- Progress in the surgical management of breast cancer: Present and future. (2015) (10)
- Hormone Replacement Therapy and Risk of Breast Cancer With a Favorable Histology (2011) (9)
- Multifocal/Multicentric Ipsilateral Invasive Breast Carcinomas with Similar Histology: Is Multigene Testing of All Individual Foci Necessary? (2018) (9)
- Recent developments: Breast cancer (2002) (9)
- Risk Factors and Racial and Ethnic Disparities in Patients With Breast Cancer-Related Lymphedema. (2022) (9)
- Breast Implant-associated Anaplastic Large Cell Lymphoma Incidence (2020) (9)
- A prospective evaluation of the durability of palliative interventions for patients with metastatic breast cancer (2010) (9)
- Was Reexcision Less Frequent for Patients with Lobular Breast Cancer After Publication of the SSO-ASTRO Margin Guidelines? (2019) (9)
- Is Sentinel Lymph Node Biopsy Required for a Core Biopsy Diagnosis of Ductal Carcinoma In Situ with Microinvasion? (2019) (9)
- Breast carcinoma with 21-gene recurrence score lower than 18: rate of locoregional recurrence in a large series with clinical follow-up (2018) (9)
- How Beneficial is Follow-Up Mammography in Elderly Breast Cancer Survivors? (2016) (9)
- Morphologic subtypes of lobular carcinoma in situ diagnosed on core needle biopsy: clinicopathologic features and findings at follow-up excision (2021) (9)
- Surgeon Attitudes and Use of MRI in Patients Newly Diagnosed with Breast Cancer (2017) (9)
- Effects of Adiposity and Exercise on Breast Tissue and Systemic Metabo-Inflammatory Factors in Women at High Risk or Diagnosed with Breast Cancer (2021) (8)
- The dual role of nipple preservation. (2006) (8)
- Predictors of Completion Axillary Lymph Node Dissection in Patients with Positive Sentinel Lymph Nodes (2009) (8)
- Surgical Oncology Forum: Tamoxifen for the Prevention of Breast Cancer in the High-Risk Woman (2000) (8)
- Blurry Boundaries: Do Epithelial Borderline Lesions of the Breast and Ductal Carcinoma In Situ Have Similar Rates of Subsequent Invasive Cancer? (2013) (8)
- Robotic mastectomy: the next major advance in breast cancer surgery? (2021) (8)
- Accuracy of AJCC staging for breast cancer patients undergoing re-excision for positive margins (1998) (8)
- Contralateral Prophylactic Mastectomy. (2017) (8)
- De-escalation of breast and axillary surgery in exceptional responders to neoadjuvant systemic treatment. (2021) (8)
- Contralateral Prophylactic Mastectomy Use After Neoadjuvant Chemotherapy (2019) (7)
- Is Residual Nodal Disease at Axillary Dissection Associated with Tumor Subtype in Patients with Low Volume Sentinel Node Metastasis After Neoadjuvant Chemotherapy? (2021) (7)
- Preoperative checkpoint inhibition (CPI) and cryoablation (Cryo) in women with early-stage breast cancer (ESBC). (2019) (7)
- Patterns of Care with a Positive Sentinel Node: Echoes of an Opportunity Missed (2009) (7)
- Breast cancer surgical practice guidelines. Society of Surgical Oncology practice guidelines. (1997) (7)
- Axillary management for young women with breast cancer varies between patients electing breast-conservation therapy or mastectomy (2020) (7)
- Patient compliance with aggressive multimodal therapy in locally advanced breast cancer (1988) (7)
- Case records of the Massachusetts General Hospital. Case 8-2013. A 48-year-old woman with carcinoma in situ of the breast. (2013) (7)
- Breast conservation among older patients with early‐stage breast cancer: Locoregional recurrence following adjuvant radiation or hormonal therapy (2021) (7)
- Lobular Histology Does Not Predict the Need for Axillary Dissection Among ACOSOG Z0011-Eligible Breast Cancers (2019) (7)
- Routine Opioid Prescriptions Are Not Necessary After Breast Excisional Biopsy or Lumpectomy Procedures (2020) (7)
- S28 Breast conservation and clear margins: Invasive or in situ involvement (2009) (7)
- Relationship Between Margin Width and Recurrence of Ductal Carcinoma In Situ Breast-conserving Surgery for 30 Years Analysis of 2996 Women Treated With (2015) (7)
- Laterality and Patient-Reported Outcomes following Autologous Breast Reconstruction with Free Abdominal Tissue: An 8-Year Examination of BREAST-Q Data (2020) (7)
- Prognostic impact of the 21-gene recurrence score in patients presenting with stage IV breast cancer. (2013) (7)
- Extent and Role of Margin Control for DCIS Managed by Breast-Conserving Surgery (2015) (6)
- Addressing the Dilemma of Contralateral Prophylactic Mastectomy With Behavioral Science. (2020) (6)
- The incidence of BRCA1 and BRCA2 variants of unknown significance varies in different ethnic populations. (2006) (6)
- Adoption of SSO-ASTRO Margin Guidelines for Ductal Carcinoma in Situ: What Is the Impact on Use of Additional Surgery? (2020) (6)
- A prospective feasibility trial to determine the significance of the sentinel node gradient in breast cancer (2008) (6)
- Axillary Surgery in DCIS: Is Less More? (2008) (6)
- Beauty and the Beast: Management of Breast Cancer After Plastic Surgery (2008) (6)
- The current status of breast cancer chemoprevention: A star is born (2007) (6)
- Access to Breast Reconstruction and Patient Perspectives on Decision Making (2016) (6)
- Optimal surgical management for high-risk populations. (2015) (6)
- Available models for breast cancer risk assessment: how accurate are they? (2003) (6)
- 10-Year Breast Cancer Outcomes in Women ≤35 Years of Age. (2020) (6)
- Clinical Management Factors Contribute to the Decision for Contralateral Prophylactic Mastectomy (CPM). (2009) (6)
- Margin width is not predictive of residual disease on re‐excision in breast‐conserving therapy (2014) (6)
- Management of ipsilateral breast tumor recurrence following breast conservation surgery: a comparative study of re-conservation vs mastectomy (2021) (6)
- The effect of ipsilateral whole breast ultrasonography on the surgical management of breast carcinoma. (2003) (6)
- Case records of the Massachusetts General Hospital. Case 35-2005. A 56-year-old woman with breast cancer and isolated tumor cells in a sentinel lymph node. (2005) (6)
- Atypical ductal hyperplasia bordering on DCIS on core biopsy is associated with higher risk of upgrade than conventional atypical ductal hyperplasia (2020) (6)
- Palpable Adenopathy Does Not Indicate High-Volume Axillary Nodal Disease in Hormone Receptor-Positive Breast Cancer (2021) (6)
- De-escalation in breast cancer surgery (2022) (5)
- What is the purpose of cancer staging? (2006) (5)
- Prevalence of BRCA1 and BRCA2 Mutations in Women Diagnosed With Ductal Carcinoma In SituClaus EB, Petruzella S, Matloff E, et al (Yale Univ, New Haven, Conn; Brigham and Women's Hosp, Boston) JAMA 293:964-969, 2005§ (2006) (5)
- When can stereotactic core biopsy replace excisional biopsy? — A clinical perspective (2004) (5)
- Analysis of a Trend Reversal in US Lumpectomy Rates From 2005 Through 2017 Using 3 Nationwide Data Sets. (2022) (5)
- Postmastectomy radiation therapy: A surgical perspective. (1999) (5)
- Oncoplastic breast consortium recommendations for mastectomy and whole breast reconstruction in the setting of post-mastectomy radiation therapy (2022) (5)
- Is It Safe to Treat Endometrial Carcinoma Endoscopically (2009) (5)
- Breast cancer (2002) (5)
- Abstract P2-15-01: Integrated immunologic assessment of tumor infiltrating lymphocytes (TILs) and peripheral blood to assess synergy of cryoablation (cryo) plus ipilimumab (ipi) in early stage breast cancer (ESBC) patients (pts) (2015) (5)
- Effects of obesity on breast aromatase expression and systemic metabo-inflammation in women with BRCA1 or BRCA2 mutations (2021) (5)
- Age as a selection factor for the local therapy of breast cancer? (1998) (5)
- Predictive Biomarkers and Personalized Medicine Frequent Mutational Activation of the PI 3 K-AKT Pathway in Trastuzumab-Resistant Breast Cancer (2012) (5)
- Influence of Age on the Clinical Outcome of Breast Cancer for Men and the Development of Second Primary Cancers (2018) (5)
- Extranodal Tumor Deposits in the Axillary Fat Indicate the Need for Axillary Dissection Among T1–T2cN0 Patients with Positive Sentinel Nodes (2020) (5)
- Ischemic Stroke in an Obese Patient Receiving Dabigatran (2013) (5)
- Surgeon perspectives on local therapy for breast cancer (2005) (5)
- Negative Estrogen Receptor and HER2 Assays at Core Biopsy of Invasive Cancers Should Be Confirmed in the Surgical Specimens. (2009) (5)
- Advances in endocrine therapy of metastatic breast cancer (2002) (4)
- Breast conserving therapy: Who and why? (2003) (4)
- Refining Risk Assessment in Women With Benign Breast Disease: An Ongoing Dilemma. (2017) (4)
- Determinants of outcome in elderly patients with positive sentinel lymph nodes. (2011) (4)
- How Often Do Sentinel Lymph Node Biopsy Results Affect Adjuvant Therapy Decisions Among Postmenopausal Women with Early-Stage HR+/HER2− Breast Cancer in the Post-RxPONDER Era? (2022) (4)
- Breast Cancer 1 MRI for breast cancer screening, diagnosis, and treatment (2011) (4)
- Parsing Pathologic Complete Response in Patients Receiving Neoadjuvant Chemotherapy for Breast Cancer. (2016) (4)
- Patterns of invasive recurrence among patients originally treated for ductal carcinoma in situ by breast-conserving surgery versus mastectomy (2021) (4)
- Concordance Between 21-Gene Recurrence Scores in Multifocal or Multicentric Breast Carcinomas Differs by Age and Histologic Subtype (2021) (4)
- Supervised machine learning model to predict oncotype DX risk category in patients over age 50 (2021) (4)
- Title Increased levels of COX-2 and prostaglandin E 2 contribute to elevated aromatase expression in inflamed breast tissue of obese women Authors and Affiliations (2012) (4)
- Phase I/II study of mogamulizumab, an anti-CCR4 antibody targeting regulatory T cells in advanced cancer patients. (2016) (4)
- Trends and controversies in multidisciplinary care of the patient with breast cancer. (2016) (4)
- De-Escalating Breast Cancer Surgery for Low-Risk Ductal Carcinoma in Situ-Reply. (2020) (4)
- Reconstruction in Women with T4 Breast Cancer after Neoadjuvant Chemotherapy: When Is It Safe? (2021) (4)
- The presence and extent of extracapsular extension (ECE) and the need for axillary lymph node dissection (ALND) in patients who meet ACOSOG Z11 eligibility criteria. (2013) (4)
- Genetic testing decisions of breast cancer patients: Results from the iCanCare study. (2015) (4)
- Improved survival in metastatic breast cancer following total excision of the primary tumor (2007) (4)
- Tamoxifen for Breast Cancer Prevention: Ready for Prime Time? (1998) (4)
- Randomized clinical trials in breast cancer. (2010) (4)
- Malignant Melanoma of the Uvea (2002) (4)
- Effect of adjuvant trastuzumab on locoregional recurrence in human epidermal growth factor receptor 2-positive breast cancer treated with post-mastectomy radiation therapy. (2013) (4)
- ASO Author Reflections: Low-Volume Sentinel Node Disease After Neoadjuvant Chemotherapy is Still an Indication for Axillary Dissection (2018) (4)
- T-cell receptor (TCR) DNA deep sequencing to evaluate clonality of tumor-infiltrating lymphocytes (TILs) in early-stage breast cancer patients (pts) receiving preoperative cryoablation (cryo) and/or ipilimumab (ipi). (2014) (4)
- Is Nodal Clipping Beneficial for Node-Positive Breast Cancer Patients Receiving Neoadjuvant Chemotherapy? (2022) (4)
- Breast Cancer Surgical Practice Guidelines (1997) (4)
- Abstract GS4-01: Impact of race and ethnicity on incidence and severity of breast cancer related lymphedema after axillary lymph node dissection: Results of a prospective screening study (2022) (3)
- Postdischarge Nonsteroidal Anti-Inflammatory Drugs Are not Associated with Risk of Hematoma after Lumpectomy and Sentinel Lymph Node Biopsy with Multimodal Analgesia (2021) (3)
- Lymphatic mapping and sentinel node biopsy: a new era in the management of solid neoplasms? (1998) (3)
- Malignant Melanoma of the Conjunctiva (2002) (3)
- The Effect of Age on Outcomes After Neoadjuvant Chemotherapy for Breast Cancer (2022) (3)
- Abstract PD5-05: Metabolic obesity, adipose inflammation and aromatase: Potential drivers of breast cancer risk in women with normal body mass index (2017) (3)
- Breast disease : a problem-based approach (1999) (3)
- A Predictive Model for the Development of Hormone-Responsive Breast Cancer (2004) (3)
- Impact of self-reported data on the acquisition of multi-generational family history and lifestyle factors among women seen in a high-risk breast screening program: a focus on modifiable risk factors and genetic referral (2017) (3)
- Surgery and prophylactic surgery in hereditary breast cancer (2021) (3)
- How much can improved molecular and pathologic discriminants change local therapy? (2008) (3)
- Reply to 'The St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017: the point of view of an International Panel of Experts in Radiation Oncology' by Kirova et al. (2017) (3)
- Re: Trends in use of adjuvant multi-agent chemotherapy and tamoxifen for breast cancer in the United States: 1975-1999. (2003) (3)
- Obesity and menopausal status as determinants of procarcinogenic breast inflammation. (2014) (3)
- P4-11-10: Perceptions, Knowledge and Satisfaction with Contralateral Prophylactic Mastectomy among Young Women with Breast Cancer. (2011) (3)
- Shared decision-making and surgical treatment for breast cancer (2004) (3)
- Tumor and systemic immune responses to preoperative (pre-op) cryoablation (cryo) plus immune therapy with ipilimumab (ipi) in early-stage breast cancer (ESBC). (2014) (3)
- Carcinoma of the Lacrimal Gland (2002) (3)
- Clinical Aspects of Breast Cancer (1996) (3)
- Margins in DCIS: Does Residual Disease Provide an Answer? (2016) (3)
- Longitudinal Prospective Evaluation of Quality of Life After Axillary Lymph Node Dissection (2022) (3)
- Images in clinical medicine. Blue hives. (2008) (3)
- Margin Width and Local Recurrence in Patients Undergoing Breast Conservation After Neoadjuvant Chemotherapy (2021) (3)
- Decision making in local therapy for breast cancer (2007) (3)
- Reply to "Implications of abnormal preoperative axillary imaging in the post Z011 era". (2016) (3)
- Effect of margin width on local recurrence (LR) in triple-negative (TN) breast cancer treated with breast-conserving therapy (BCT). (2013) (3)
- Options for management of the axillary lymph nodes in breast cancer (2001) (3)
- Leveraging the Benefits of Systemic Therapy to Tailor Surgery. (2017) (3)
- Association of Genetic Testing Results with Mortality Among Women with Breast Cancer or Ovarian Cancer. (2021) (2)
- Breast cancer treatment according to pathogenic variants in cancer susceptibility genes in a population-based cohort. (2019) (2)
- Trends and Controversies in Multi-Disciplinary Care of the Breast Cancer Patient (2017) (2)
- Adoption of new breast cancer therapies: Is evidence important? (2008) (2)
- Diseases of the Breast 4/e (2009) (2)
- Abstract PD8-01: Microscopic extracapsular extension in sentinel lymph nodes does not mandate axillary dissection in Z0011-eligible patients (2019) (2)
- MARGINS IN BREAST CANCER SURGERY (2012) (2)
- Axillary vs Sentinel Lymph Node Dissection for Invasive Breast Cancer—Reply (2011) (2)
- Hormone Replacement Therapy and Risk of Breast Cancer with a Favorable Histology: Results of the Iowa Womenʼs Health Study (1999) (2)
- Impact of Endocrine Therapy Adherence on Outcomes in Elderly Women with Early-Stage Breast Cancer Undergoing Lumpectomy Without Radiotherapy (2022) (2)
- Association Between Local Anesthetic Dosing, Postoperative Opioid Requirement, and Pain Scores After Lumpectomy and Sentinel Lymph Node Biopsy with Multimodal Analgesia (2021) (2)
- Addressing the problem of overtreatment in breast cancer (2022) (2)
- Association of MRI and locoregional recurrence (LRR) rates in ductal carcinoma in situ (DCIS) patients treated with or without radiation therapy (RT). (2013) (2)
- Tamoxifen to prevent breast cancer. (2000) (2)
- ASO Author Reflections: Axillary Staging in Node-Positive Breast Cancer Patients Treated with Neoadjuvant Chemotherapy—Beyond Clinical Trials (2020) (2)
- Correlates of local therapy for women with DCIS (2005) (2)
- Reduced/Absent PTEN Expression Is More Common in HER2 Non-Amplified DCIS. (2009) (2)
- Feasibility of breast-conservation therapy and hypofractionated radiation in the setting of prior breast augmentation. (2020) (2)
- Inflammatory Breast Cancer: Still Poorly Characterized (2007) (2)
- Abstract P4-13-01: A pilot study of pre-operative (Pre-op), single-dose ipilimumab (Ipi) and/or cryoablation (Cryo) in women (pts) with early stage/resectable breast cancer (ESBC) (2013) (2)
- Breast cancer risk correlates with level of atypia in prophylactic mastectomy(PM) specimens (2004) (2)
- Tumor-Nipple Distance of ≥ 1 cm Predicts Negative Nipple Pathology After Neoadjuvant Chemotherapy (2021) (2)
- Trend Analysis on Reoperation After Lumpectomy for Breast Cancer-Reply. (2018) (2)
- Risk for subsequent breast cancer after lobular carcinoma in situ: Do clinical factors matter? (2010) (2)
- Abstract P2-12-03: Impact of the SSO-ASTRO consensus guidelines on invasive margins on the re-excision rate among patients undergoing breast conserving surgery (BCS) (2018) (2)
- Sentinel lymph node biopsy: benefits and limitations. (2003) (2)
- Contralateral prophylactic mastectomy decision-making in the population-based iCanCare study of early-stage breast cancer patients: Knowledge and physician influence. (2015) (2)
- The National Cancer Data Base: What does it mean to the community surgeon? (2000) (2)
- Can We Forgo Sentinel Lymph Node Biopsy in Women Aged ≥ 50 Years with Early-Stage Hormone-Receptor-Positive HER2-Negative Special Histologic Subtype Breast Cancer? (2022) (2)
- Letter to Editor re: Ridner et al.: “A Randomized Trial Evaluating Bioimpedance Spectroscopy Versus Tape Measurement for the Prevention of Lymphedema Following Treatment for Breast Cancer: Interim Analysis” (2019) (2)
- Does Failure to Achieve Pathologic Complete Response with Neoadjuvant Chemotherapy Identify Node-Negative Patients Who Would Benefit from Postmastectomy Radiation or Regional Nodal Irradiation? (2020) (2)
- The End of the Beginning: Society of Surgical Oncology 2013 Presidential Address (2014) (2)
- In reply to Dixon and Thomas. (2014) (2)
- Is local recurrence higher among patients who downstage to breast conservation after neoadjuvant chemotherapy? (2021) (2)
- Blood Biomarkers Reflect the Effects of Obesity and Inflammation on the Human Breast Transcriptome. (2021) (2)
- Management of close margins in invasive breast cancer (2007) (2)
- A Pattern of Care Analysis of Nodal Irradiation in the Post Z0011 Era: Results of a Large Prospective Study (2015) (2)
- The local therapy for breast cancer as a model for evidence-based medical care. (2002) (2)
- Axillary Adenopathy as the Initial Presentation of Breast Cancer (2002) (2)
- The role of magnetic resonance imaging in the breast cancer patient. (2009) (2)
- Shared decision-making and surgical treatment for breast cancer. (2004) (2)
- Omission of Intraoperative Frozen Section May Reduce Axillary Overtreatment Among Clinically Node-Negative Patients Having Upfront Mastectomy (2022) (2)
- Patient and Tumor Characteristics Associated with Primary Tumor Resection in Women with Stage IV Breast Cancer: Analysis of 1988–2003 SEER Data (2009) (2)
- Significantly Higher Pathologic Complete Remission Rate After Neoadjuvant Therapy With Trastuzumab, Paclitaxel, and Epirubicin Chemotherapy: Results of a Randomized Trial in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast CancerBuzdar AU, Ibrahim NK, Francis D, et al (Univ of Texas (2006) (2)
- What Does a Fellow Need to Know to Build a Successful Academic Clinical Research Career?Advice From Monica Morrow, MD. (2005) (2)
- Abstract P3-13-07: Are there patients with T1-T2, node-negative breast cancer who are high-risk for locoregional recurrence? (2017) (2)
- Part II. The cancer program of the American College of Surgeons Commission on Cancer (2001) (2)
- Impact of the American College of Surgeons Oncology Group Z0011 Criteria Applied to a Contemporary Patient Population (2013) (1)
- Abstract OT3-1-01: A pilot study of single-dose ipilimumab and/or cryoablation in women with early-stage breast cancer scheduled for mastectomy (2012) (1)
- Does preoperative MRI accurately stratify early-stage HER2 + breast cancer patients to upfront surgery vs neoadjuvant chemotherapy? (2021) (1)
- The management of mammographically detected ductal carcinoma in situ: what is the best treatment? (1996) (1)
- Ductal Carcinoma In Situ: How Much Treatment Is Enough, How Much Is Too Much? (2016) (1)
- Prevalence and Impact of Variants of Uncertain Significance on Local Therapy Decision-Making in Newly Diagnosed Breast Cancer Patients (2017) (1)
- National treatment trends for ductal carcinoma in situ of the breast. Arch Surg 1997 Jun;132:660-665. (1998) (1)
- ASO Author Reflections: Nodal Downstaging and Conversion to Breast-Conserving Surgery Following Neoadjuvant Endocrine Therapy (2020) (1)
- Abstract PS6-16: Outcomes for metaplastic breast cancer differ by histologic subtype (2021) (1)
- Neoadjuvant Chemotherapy for Breast Cancer In the Elderly: Are We Accomplishing Our Treatment Goals? (2022) (1)
- Patterns and correlates of breast reconstruction: results of a population based study. (2004) (1)
- Recurrence risk perception and quality of life after treatment of breast cancer. (2016) (1)
- Outcome following axillary staging in early breast cancer (2008) (1)
- Personalized surgical treatment of breast cancer (2007) (1)
- Confusion Over Differences in Registration and Randomization Criteria for the LORIS (Low-Risk DCIS) Trial: A Reply (2017) (1)
- Timing of Chemotherapy and Patient-Reported Outcomes After Breast-Conserving Surgery and Mastectomy with Immediate Reconstruction (2023) (1)
- Increased trunk fat is associated with altered gene expression in breast tissue of normal weight women (2022) (1)
- Evaluation of local and distant recurrences pattern in patients with triple negative breast cancer according to age. (2015) (1)
- Matched T cell repertoire analysis of peripheral blood and tumor-infiltrating lymphocytes (TILs) in early stage breast cancer (ESBC) patients (pts) treated with pre-operative cryoablation (cryo) and/or Ipilimumab (Ipi) (2014) (1)
- Is Expert Breast Pathology Assessment Necessary for the Management of Ductal Carcinoma In Situ (2006) (1)
- Axillary Staging Is Not Justified in Postmenopausal Clinically Node-Negative Women Based on Nodal Disease Burden (2022) (1)
- Integrating cancer care: Patient and practice management processes among surgeons who treat breast cancer. (2009) (1)
- Impact of molecular subtype on presenting characteristics of T1a,b tumors. (2009) (1)
- Quality Cancer Care (2018) (1)
- BREAST CANCER SURGICAL PRACTICE GUIDELINES : SCOPE AND FORMAT OF GUIDELINES (1997) (1)
- The surgeon's role in breast cancer chemoprevention. (2001) (1)
- Reply to A prospective feasibility trial to determine the significance of the sentinel node gradient in breast cancer (2009) (1)
- Is Regional Nodal Radiotherapy Necessary for Patients With cN1 and ypN0 Breast Cancer After Neoadjuvant Chemotherapy?-Reply. (2022) (1)
- Erratum to: Decreasing Recurrence Rates for Ductal Carcinoma In Situ: Analysis of 2996 Women Treated with Breast-Conserving Surgery Over 30 Years (2015) (1)
- The effect of margin status on local recurrence following breast conservation and radiation therapy for DCIS. (2007) (1)
- POINT-COUNTERPOINT. Routine Preoperative MRI: Time to Face the Facts (2012) (1)
- Breast-conserving Surgery Without Radiation Therapy for Invasive Cancer. (2021) (1)
- Combined Hormone Therapy and Breast Cancer (2017) (1)
- Abstract P4-04-11: Preferential expression of the chemokine receptor 8 (CCR8) on regulatory T cells (Treg) infiltrating human breast cancers represents a novel immunotherapeutic target (2016) (1)
- Chapter 4 Physical Examination of the Breast (2009) (1)
- High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants (2019) (1)
- Increasing Access to Modern Multidisciplinary Breast Cancer Care (1998) (1)
- Breast-Conserving Surgery After Neoadjuvant Anthracycline-Based Chemotherapy for Large Breast Tumors (2006) (1)
- Local Recurrence is Frequent After Heroic Mastectomy for Classically Inoperable Breast Cancers (2021) (1)
- Is Surgical Excision of Focal Atypical Ductal Hyperplasia Warranted? Experience at a Tertiary Care Center. (2023) (1)
- Abstract 179: Breast Implant-associated Anaplastic Large Cell Lymphoma Incidence: Determining An Accurate Risk (2020) (1)
- Breast-Cancer Prevention with Antiestrogens (2009) (1)
- ASO Visual Abstract: Who Are We Missing: Does Engagement in Patient-Reported Outcome Measures for Breast Cancer Vary by Age, Race, and Disease Stage? (2022) (1)
- Patient and surgeon correlates of shared decision making for surgical breast cancer treatment. (2006) (1)
- Who Are We Missing: Does Engagement in Patient-Reported Outcome Measures for Breast Cancer Vary by Age, Race, or Disease Stage? (2022) (1)
- Retraction: Increased Levels of COX-2 and Prostaglandin E2 Contribute to Elevated Aromatase Expression in Inflamed Breast Tissue of Obese Women. (2021) (1)
- Improving local control in breast conserving therapy: to clip or not to clip? (1996) (1)
- The Role of Galactography in Patients with Postoperative Nipple Discharge (1997) (1)
- Incidental Breast Lesions Identified by 18F-Fluorodeoxyglucose- (2010) (1)
- Obesity promotes breast epithelium DNA damage in women carrying a germline mutation in BRCA1 or BRCA2 (2023) (1)
- Nipple-Sparing Mastectomy and Immediate Reconstruction: A Propensity Score–Matched Analysis of Satisfaction and Quality of Life (2022) (1)
- Insurance Policies for Prophylactic Surgery: To cover or Not to Cover? (2000) (1)
- Reply to M.D. Lagios et al (2010) (1)
- Surgeon specialization and patient satisfaction with breast cancer treatment (2007) (1)
- Primary outcomes analysis of a multicenter randomized controlled trial of an interactive decision tool for patients with breast cancer. (2017) (1)
- How Much Pain Will I Have After Surgery? A Preoperative Nomogram to Predict Acute Pain Following Mastectomy (2022) (1)
- Positron emission tomography (PET) and estrogen receptor (ER) ligand in patients with invasive breast cancer. (2010) (1)
- Poor response to neoadjuvant chemotherapy in metaplastic breast carcinoma (2021) (1)
- Abstract P2-19-01: Impact of breast reconstruction approach on patient-reported satisfaction with cosmetic outcomes after mastectomy with and without radiotherapy (2013) (1)
- Patient-Reported Outcome Measures for Patients Who Have Clinical T4 Breast Cancer Treated via Mastectomy with and Without Reconstruction (2022) (1)
- The status of post mastectomy radiation (PMR) in the United States: a patterns of care study (PCS) (2002) (1)
- Case 8-2013: A woman with carcinoma in situ of the breast. (2013) (1)
- The Effect of Radiation Timing in Breast Cancer Patients with Implant-Based Reconstruction (2014) (1)
- Brain and Spinal Cord (2002) (1)
- Patient characteristics associated with the decision to undergo bilateral prophylactic mastectomy for lobular carcinoma in situ. (2011) (1)
- Outcomes of Breast Cancer Patients with High Volume of Residual Disease Following Neoadjuvant Chemotherapy. (2022) (1)
- The Effect of Margin Width on Local Recurrence of Triple Negative Breast Cancer (2014) (1)
- Treatment selection in ductal carcinomain situ (2001) (1)
- Abstract PD04-05: Molecular predictors for type of recurrence following conservative treatment for DCIS (2012) (1)
- Proportion of cytologically evaluable samples from duct lavage procedures (2002) (1)
- Residual disease in DCIS: an excision too far? (2003) (1)
- The need for axillary lymph node dissection in T1/T2 breast cancer surgery--reply to counterpoint. (2013) (1)
- Abstract P4-04-12: Both metabolic syndrome and statin use are more common in women with breast inflammation (2015) (1)
- Regional Nodal Management in the Setting of Up-Front Surgery. (2022) (1)
- Correction to: Is Low-Volume Disease in the Sentinel Node After Neoadjuvant Chemotherapy an Indication for Axillary Dissection? (2020) (1)
- Disparities in Cancer Care: Educational Initiatives (2022) (1)
- ASO Author Reflections: Early-Stage Lobular Breast Cancer: Axillary Treatment in the Z0011 Era (2019) (1)
- Clonal relatedness between lobular carcinoma in situ and synchronous malignant lesions (2012) (1)
- Prophylactic contralateral surgery: current recommendations and techniques (2009) (1)
- Focal Therapy for Prostate Cancer: Evolutionary Parallels to Breast Cancer Treatment (2022) (1)
- Can We Successfully De-Escalate Axillary Surgery in Women Aged ≥ 70 Years with Ductal Carcinoma in Situ or Early-Stage Breast Cancer Undergoing Mastectomy? (2022) (1)
- Imaging methods to screen women with breast implants (2000) (1)
- The authors' reply. (2019) (0)
- Abstract GS4-02: Oncological Outcomes Following Omission of Axillary Lymph Node Dissection in Node Positive Patients Downstaging To Node Negative with Neoadjuvant Chemotherapy: the OPBC-04/EUBREAST-06/OMA study (2023) (0)
- Professionalism in the Approach to the Patient (2010) (0)
- Response to: “Letter to the Editor: Is Low-Volume Disease in the Sentinel Node After Neoadjuvant Chemotherapy an Indication for Axillary Dissection? Miscalculation of Sensitivity and False Negative Rate” (2020) (0)
- The appropriate extent of surgery for early-stage breast cancer. (2012) (0)
- Cellular, Biochemical, and Molecular Targets in Breast Cancer (2011) (0)
- Use of a supervised machine learning model to predict Oncotype DX risk category in node-positive patients older than 50 years of age (2022) (0)
- Abstract AL-2: William L. McGuire memorial lecture – Local therapy in the molecular era: Relevant or relic? (2013) (0)
- Breast Conservation in Patients With Multiple Ipsilateral Synchronous CancersKaplan J, Giron G, Tartter Pl, et al (St Luke's-Roosevelt Hosp Ctr, New York; Mount Sinai Med Ctr, New York) J Am Coll Surg 197:726-729, 2003§ (2006) (0)
- Surgical Margins in Breast-Conserving Surgery (2019) (0)
- Ductal lavage (DL) findings in women with mammographic microcalcifications undergoing biopsy (2006) (0)
- 1080 : A Phase II Study of Four-Week Radiation for Breast Cancer Using Hypofractionated Intensity Modulated Radiation Therapy (IMRT) With an Incorporated Boost (2006) (0)
- Late axillary recurrence after negative SLNB. (2014) (0)
- New Initiatives Underway at the ACoS Commission on Cancer (2000) (0)
- Clinical Applications of Stereotactic Biopsy (1995) (0)
- ASO Author Reflections: A Negative Axillary Clinical Exam Adequately Identifies Clinically Node-Positive Patients who Downstage After NAC and are Candidates for SLNB (2019) (0)
- ASO Visual Abstract: Can We Forego Sentinel Lymph Node Biopsy in Women ≥50 Years of Age with Early-Stage Hormone Receptor-Positive HER2-Negative Special Histologic Subtype Breast Cancer? (2022) (0)
- Assessing Outcomes in the Management of Postmastectomy Local-Regional Recurrences in Breast Cancer (2017) (0)
- Symposium overview: Estrogens and antiestrogens in managing the patient with breast cancer (2007) (0)
- A 47-YEAR-OLD WOMAN WITH DUCTAL CARCINOMA IN SITU OF THE BREAST. AUTHOR'S REPLY (1996) (0)
- Statistical machine learning model to predict Oncotype DX risk category in women over age 50. (2020) (0)
- Abstract P2-06-03: Obesity is associated with DNA damage in the breast epithelium of BRCA1 and BRCA2 mutation carriers: A role for estrogens & strategies for prevention (2022) (0)
- Obesity promotes breast epithelium DNA damage in BRCA mutation carriers (2022) (0)
- Clinical Examination Following Preoperative Chemoradiation for Rectal Cancer Is Not a Reliable Surrogate End PointGuillem JG, Chessin DB, Shia J, et al (Mem Sloan-Kettering Cancer Ctr, New York) J Clin Oncol 23:3475-3479, 2005§ (2006) (0)
- Smoking Does Not Affect the Clinical Presentation of Breast Cancer (2007) (0)
- 33. The future of trials in cancer surgery: The U.S. perspective—Today's strengths and threats (2012) (0)
- Characteristics and Outcomes of Early-stage Breast Cancer in Mastectomy Patients with Low-volume Sentinel Node Disease and no Axillary Treatment (2011) (0)
- Involvement and Receipt of Mastectomy Among Racially and Ethnically Diverse Breast Cancer Patients (2009) (0)
- ASO Visual Abstract: Patient-Reported Outcome Measures in Patients with Clinical T4 Breast Cancer Treated with Mastectomy With and Without Reconstruction (2022) (0)
- Is surgical evaluation of the axilla necessary for locoregional control in breast conserving therapy of early stage mammary cancer in all patients (2001) (0)
- Breast Cancer, Eva Singletary, MD, editor, 365 pages, illustrated; $89.95. New York: Springer-Verlag Inc, 1999; ISBN: 0-387-98369-4 (2000) (0)
- Curret Perceptions Regarding Surgical Margin Status After Breast-Conserving Therapy: Results of a SurveyTaghian A, Mohiuddin M, Jagsi R, et al (Harvard Med School, Boston) Ann Surg 241:629-639, 2005§ (2006) (0)
- Abstract P4-06-07: PI3K Mutations Are More Common in Low Grade DCIS (2010) (0)
- Introduction to sessions on 'What can surgeons do for us (and we for them): radiology, pathology, molecular biology and local therapy' (2008) (0)
- Abstract P3-07-01: Clonal Relatedness between Lobular Carcinoma In Situ and Synchronous Malignant Lesions: Analysis of Fresh Frozen Tissue Using SNP Array (2010) (0)
- Genetic Testing in Ultra-Young Breast Cancer Patients: A Single Institution Analysis of Breast Cancer Patients ≤ 35 Years at Diagnosis (2019) (0)
- Surgeon influence on receipt of contralateral prophylactic mastectomy for breast cancer. (2017) (0)
- Quality of Life and Breast Cancer Surgery. (2021) (0)
- P0008 Validating the link between obesity and breast inflammation in women with breast cancer (2014) (0)
- Radiotherapy in Breast Cancer (2016) (0)
- The Effect of Surgeon Referral and a Radiation Oncologist Productivity-Based Metric on Radiation Therapy Receipt Among Elderly Women With Early Stage Breast Cancer: Analysis From a Tertiary Cancer Network (2021) (0)
- Determinants of surgeon referral and radiation therapy receipt following breast conservation among older women with early-stage breast cancer (2021) (0)
- OncotypeDX Risk Stratification in Early Stage Breast Cancer: When is Accelerated Partial Breast Irradiation (APBI) Safe? (2018) (0)
- ASO Author Reflections: Residual Disease in the Breast Following Neoadjuvant Chemotherapy Does Not Mandate Routine Post-Mastectomy Radiation Therapy/Regional Nodal Irradiation (2020) (0)
- Effects of obesity on breast aromatase expression and systemic metabo-inflammation in women with BRCA1 or BRCA2 mutations (2021) (0)
- Abstract P4-06-11: Gene Expression Profiling Identifies Potential Precursor Genes in Lobular Carcinoma In Situ (2010) (0)
- Does biologic subtype and pathologic response after neoadjuvant chemotherapy predict locoregional recurrence? (2014) (0)
- Association of Attending SurgeonWith Variation in the Receipt of Genetic Testing After Diagnosis of Breast Cancer (2018) (0)
- RESPONSE (2000) (0)
- Abstract P3-17-03: Raising the level of cancer care around the world: The feasibility and perceived benefit of a virtual breast tumor board (2022) (0)
- Routine Preoperative MRI for Breast Carcinoma. Authors' reply (2010) (0)
- Do non-classic invasive lobular carcinomas derive a benefit from neoadjuvant chemotherapy? (2022) (0)
- Should ACOSOG Z0011 change practice with respect to axillary lymph node dissection for a positive sentinel lymph node biopsy in breast cancer? (2012) (0)
- Abstract P3-18-06: Satisfaction and physical wellbeing after breast conserving therapy: Clinical predictors and reference values using the BREAST-Q (2022) (0)
- White adipose tissue inflammation and breast cancer progression. (2015) (0)
- Seminars in Breast Disease: Introduction (2004) (0)
- Could breast cancer patients have been targeted for chemoprevention prior to their diagnosis (2004) (0)
- Cancer-specific mortality associated with germline genetic testing results among women with breast cancer or ovarian cancer treated with chemotherapy. (2021) (0)
- Surgeon influence on receipt of contralateral prophylactic mastectomy: Does it matter who you see for breast cancer surgery? (2018) (0)
- Impact of 1st surgeon recommendation against CPM on patient treatment experiences and satisfaction. (2016) (0)
- A Randomized Trial Comparing Axillary Dissection to No Axillary Dissection in Older Patients With T1N0 Breast Cancer: Results After 5 Years of Follow-up (2006) (0)
- New Guidelines on the Adequacy of Lumpectomy Margin Width in Patients with Ductal Carcinoma In Situ (2017) (0)
- Reply to “Multicentric Ipsilateral Invasive Breast Carcinomas Might Have Higher 21-Gene Recurrence Score Compared with Multifocal Ipsilateral Invasive Breast Carcinomas” (2018) (0)
- SPECIAL SERIES: LOCOREGIONAL MANAGEMENT OF BREAST CANCER (2020) (0)
- Does a brief surgeon training in negotiation theory principles decrease rates of contralateral prophylactic mastectomy? (2023) (0)
- In Reply. (2016) (0)
- Recommend Lumpectomy with or without Radiation (2016) (0)
- Abstract P1-06-03: Validating the link between obesity and breast inflammation in women with breast cancer (BC) (2013) (0)
- Predicting involvement of 4 or more lymph nodes: does it matter? (2010) (0)
- ASO Author Reflections: Heroic Mastectomy for Chemoresistant Disease: A Complex Decision (2021) (0)
- Changes in the Diagnoses of Breast Core Needle Biopsies on Second Review at a Tertiary Care Center (2022) (0)
- ASO Author Reflections: Do We Need to Clip Metastatic Lymph Nodes at Diagnosis and Localize Them After Neoadjuvant Chemotherapy? (2022) (0)
- Abstract ES7-1: Challenges in the management of locoregional recurrence (2018) (0)
- Abstract P5-08-09: Does Breast Inflammation Contribute to Lymphedema Risk in Patients Treated with Axillary Lymph Node Dissection? (2023) (0)
- Age, Tumor Subtype, and Locoregional Recurrence in Operable Breast Cancer Patients Treated With Adjuvant Therapies (2014) (0)
- Comment on: Trends in use of adjuvant multi-agent chemotherapy and tamoxifen for breast cancer in the United States: 1975-1999. Authors' reply (2003) (0)
- Magnetic resonance imaging for diagnosis, staging, and follow-up (2009) (0)
- Abstract P6-13-07: Chemotherapy with and without trastuzumab or no treatment in elderly patients with HER2 amplified breast cancer at a single center (2018) (0)
- Characteristics and Outcomes of Breast Cancer Patients Who Received Immediate Reconstruction and Postmastectomy Radiation Following Neoadjuvant Chemotherapy (2014) (0)
- Patterns and Correlates of Knowledge , Communication , and Receipt of Breast Reconstruction in a Modern Population-Based Cohort of Patients with Breast Cancer Supplemental digital content (2019) (0)
- Preface to the fifth edition (2014) (0)
- Does timing of chemotherapy impact breast satisfaction after breast conservation therapy and mastectomy with immediate reconstruction? (2021) (0)
- Prophylactic surgery for breast cancer prevention (2000) (0)
- P47. REVERSAL OF TRENDS IN U.S. BREAST SURGERY RATES: AN ANALYSIS FROM 2005-2017 USING THREE NATIONWIDE DATASETS (2022) (0)
- Can we identify women at risk for receptor (ER) positive breast cancer (2004) (0)
- Correlates of patient referral to surgeons for treatment of breast cancer. (2006) (0)
- Abstract P2-02-06: Genetic counseling, germline genetic testing, and impact of results in patients with newly diagnosed breast cancer (2017) (0)
- Abstract BL2: Changing paradigms in the local therapy of breast cancer: Making less more (2017) (0)
- Patterns and Correlates of Patient Referral to Surgeons for Treatment of Breast Cancer (2007) (0)
- ASO Visual Abstract: Omission of Intraoperative Frozen Section May Reduce Axillary Overtreatment Among Clinically Node-Negative Patients Having Upfront Mastectomy (2022) (0)
- Abstract P2-16-06: In-breast pathologic complete response (pCR) following neoadjuvant chemotherapy predicts nodal pCR in early stage breast cancer (2020) (0)
- At surgery for a core needle biopsy diagnosis of ductal carcinoma in situ with microinvasion: Is sentinel lymph node biopsy required? (2018) (0)
- Reply to letter: "Anaplastic large cell lymphomas and breast implants". (2014) (0)
- Breast Cancer in Elderly Women (2020) (0)
- Diagnosis, Treatment and Prognosis of Internal Mammary Lymph Node Recurrence in Breast Cancer Patients (2006) (0)
- Patterns of Locoregional Failure in Patients With Operable Breast Cancer Treated by Mastectomy and Adjuvant Chemotherapy With or Without Tamoxifen and Without Radiotherapy: Results From Five National Surgical Adjuvant Breast and Bowel Project Randomized Clinical TrialsTaghian A, Jeong J-H, Mamounas (2006) (0)
- ASO Visual Abstract: Margin Width and Local Recurrence in Patients Undergoing Breast Conservation after Neoadjuvant Chemotherapy (2021) (0)
- Axillary lymph node dissection: Dead or still alive? (2023) (0)
- P5-14-13: Favorable Prognosis in Patients with T1a,b Node-Negative Triple Negative Breast Cancers Treated with Multimodality Therapy. (2011) (0)
- ASO Author Reflections: Rethinking Palpable Adenopathy as a Marker of High-Volume Axillary Nodal Disease in Hormone Receptor-Positive Breast Cancer (2021) (0)
- Long-term Outcome After Breast-Conservation Treatment With Radiation for Mammographically Detected Ductal Carcinoma In Situ of the Breast (2006) (0)
- Approach to the Patient with a Breast Mass (2019) (0)
- ASO Author Reflections: Biological Diversity of Histologic Subtypes (2018) (0)
- PG 1.01 Surgical management of early breast cancer 2015 (2015) (0)
- The Role of Axillary Node Dissection in the Post Z0011 Era (2015) (0)
- ASO Visual Abstract: Interpreting the BREAST-Q for Breast-Conserving Therapy-Minimal Important Differences and Clinical Reference Values. (2023) (0)
- Abstract 1928: Prediction of neoadjuvant treatment outcomes with multimodal data integration in breast cancer (2022) (0)
- Sarcoma of the Orbit (2002) (0)
- Association of intraoperative opioids with improved recurrence-free survival in triple-negative breast cancer. (2020) (0)
- Abstract PD4-05: Axillary recurrence is a rare event in node-positive patients. treated with sentinel node biopsy alone after neoadjuvant chemotherapy: Results of a prospective study (2021) (0)
- Abstract P2-03-03: Feasibility of evaluation of breast tissue using confocal microscopy with strip mosaicing (2013) (0)
- Falsely Low Carboxyhemoglobin Level after Hydroxocobalamin (2012) (0)
- Correction to: Lymph Node Status in Breast Cancer Does Not Predict Tumor Biology (2018) (0)
- ASO Visual Abstract: Axillary Staging Is Not Justified in Postmenopausal Clinically Node-Negative Women Based on Nodal Disease Burden (2022) (0)
- Interpreting the BREAST-Q for Breast-Conserving Therapy: Minimal Important Differences and Clinical Reference Values. (2023) (0)
- Does preoperative MRI improve clinical outcomes in breast cancer (2013) (0)
- Neoadjuvant Chemotherapy, Postmastectomy Radiation Therapy, and Immediate Reconstruction: Patient Selection and Outcomes. (2016) (0)
- Mastectomy rates in relation to adoption of a margin guideline. (2017) (0)
- ASO Visual Abstract: Association Between Local Anesthetic Dosing, Postoperative Opioid Requirement, and Pain Scores After Lumpectomy and Sentinel Lymph Node Biopsy With Multimodal Analgesia (2021) (0)
- Abstract PD10-01: Trends in genetic testing and results for women diagnosed with breast cancer or ovarian cancer, 2013-2017 (2021) (0)
- ASO Author Reflections: Discharge Without Opioids After Lumpectomy with Sentinel Node Biopsy Should be the Norm, Not the Exception (2020) (0)
- Reply to: “Ketorolac Following Mastectomy: Is There an Increased Risk of Reoperation?” (2021) (0)
- ASO Visual Abstract: Timing of Chemotherapy and Patient-Reported Outcomes After Breast-Conserving Surgery and Mastectomy with Immediate Reconstruction (2023) (0)
- Frequency of locoregional recurrence among locally advanced HER2-positive breast cancer treated with modern multimodality therapy. (2018) (0)
- Two distinct molecular subgroups of lobular carcinoma in situ associated with invasive lobular carcinoma. (2010) (0)
- Guidelines Do Not Proscribe Surgeons Performing Genetic Testing-Reply. (2019) (0)
- ASO Visual Abstract: Is Surgical Excision of Focal Atypical Ductal Hyperplasia Warranted? Experience at a Tertiary Care Center. (2023) (0)
- Hormone replacement therapy and risk of breast cancer with a favorable histology: results of the Iowa Women's Health Study (1999) (0)
- Modified radical mastectomy (2000) (0)
- The evolving role of axillary dissection. (2009) (0)
- Mammary endoscopy (ductoscopy) to guide surgical excision in women with spontaneous nipple discharge (2004) (0)
- Exploring the added clinical value of breast MRI after contrast-enhanced spectral mammography in patients with invasive lobular carcinoma (2018) (0)
- Carcinoma of the Conjunctiva (2002) (0)
- Reply to L.B. Marks et al. (2017) (0)
- De-escalation in breast cancer surgery (2022) (0)
- Title: A pilot study of preoperative single-dose ipilimumab and/or cryoablation in women with early- stage breast cancer with comprehensive immune profiling. Authors and affiliations: (2016) (0)
- How much is too much? Multidisciplinary management of elderly early-stage breast cancer (BC) patients. (2020) (0)
- Early and Late Complications After Radiofrequency Ablation of Malignant Liver Tumors in 608 Patients (2006) (0)
- The clinical impact and outcomes of immunohistochemistry-only metastases in breast cancer. (2009) (0)
- Changes in Management Techniques and Patterns of Disease Recurrence Over Time in Patients With Breast Carcinoma Treated With Breast-Conserving Therapy at a Single InstitutionPass H, Vicini FA, Kestin LL, et al (William Beaumont Hosp, Royal Oak, Mich) Cancer 101:713-720, 2004§ (2006) (0)
- In Reply (2007) (0)
- Point It Is Not Always Necessary to Do Axillary Dissection for T 1 and T 2 Breast Cancer (2013) (0)
- Revision o f t he A merican J oint C ommittee o n C ancer Staging S ystem f or B reast C ancer (2011) (0)
- Prevention of breast cancer (2006) (0)
- ASO Author Reflections: Engagement in Patient-Reported Outcomes for Breast Cancer (2022) (0)
- the Breast Tissue of Obese Women with Breast Cancer Inflammation and Increased Aromatase Expression Occur in (2011) (0)
- he clinical impact and outcomes of mmunohistochemistry-only metastasis in breast cancer (0)
- Contralateral Prophylactic MastectomyDecisions in a Population-Based Sample of Patients With Early-Stage Breast Cancer (2017) (0)
- Response to Comment on ‘When can stereotactic core biopsy replace excisional biopsy?’ (1996) (0)
- Increased trunk fat is associated with altered gene expression in breast tissue of normal weight women (2022) (0)
- Impact of Approximated Biological Subtype on Locoregional Recurrence in Women With Node-Negative Breast Cancer Treated With Mastectomy (2014) (0)
- Crafting a JAMA Oncology Clinical Challenge. (2019) (0)
- Patient Involvement in Surgery Treatment Decisions for Breast CancerKatz SJ, Lantz PM, Janz NK, et al (Univ of Michigan, Ann Arbor; Veterans Affairs Ann Arbor Healthcare System, Mich; Wayne State Univ, Detroit; et al) J Clin Oncol 23:5526–5533, 2005§ (2007) (0)
- Five-year Results of a Phase II Study of Hypofractionated IMRT with an Incorporated Boost for Breast Cancer (2009) (0)
- The effect of margin status on local recurrence following breast conservation and radiation therapy for DCIS (2007) (0)
- P015 Metabolic syndrome and statin use are associated with pro-estrogenic breast inflammation (2015) (0)
- Erratum to: Axillary Micrometastases and Isolated Tumor Cells Are Not an Indication for Post-mastectomy Radiotherapy in Stage 1 and 2 Breast Cancer (2017) (0)
- Radiation Field Design and Regional Control in Breast Cancer Patients with Minimal Sentinel Lymph Node Disease after Breast Conserving Surgery and No Axillary Lymph Node Dissection (2011) (0)
- Abstract 785: Gene expression profiling identifies two stable clusters of lobular carcinoma in situ (2010) (0)
- A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer (2006) (0)
- ASO Visual Abstract: Local Recurrence is Frequent After Heroic Mastectomy for Classically Inoperable Breast Cancers (2021) (0)
- Organ‐based subspecialization in surgical oncology: Fragmentation as a path to progress? (2007) (0)
- ASO Author Reflections: Refining Risk Assessment in Node-Positive Breast Cancer Patients Eligible for Sentinel Lymph Node Biopsy Alone (2020) (0)
- Quality of Life Following Breast-Conserving Therapy or Mastectomy: Results of a 5-Year Prospective Study (2006) (0)
- Breast carcinoma with 21-gene recurrence score lower than 18: rate of locoregional recurrence in a large series with clinical follow-up (2018) (0)
- Abstract 5275: Alternate mechanisms of PI3K pathway activation among subtypes of ductal carcinoma in situ suggest distinct pathways for progression to invasive disease (2010) (0)
- Breast-conserving Therapy Achieves Equivalent Locoregional Outcomes Compared to Mastectomy in Women With T1-2N0 Triple Negative Breast Cancer (2012) (0)
- Commentary (1995) (0)
- ASO Visual Abstract: How Much Pain Will I Have After Surgery? A Preoperative Nomogram to Predict Acute Pain Following Mastectomy (2022) (0)
- Biomineralogical signatures of breast microcalcifications (2023) (0)
- ASO Visual Abstract: How Often Do Sentinel Lymph Node Biopsy Results Affect Adjuvant Therapy Decisions Among Postmenopausal Women with Early-Stage HR+/HER2− Breast Cancer in the Post-RxPONDER Era? (2022) (0)
- ASO Visual Abstract: Longitudinal Prospective Evaluation of Quality of Life After Axillary Lymph Node Dissection (2022) (0)
- Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study population (2017) (0)
- Trends in germline genetic testing and results into survivorship for women diagnosed with breast cancer or ovarian cancer, 2013 to 2017. (2020) (0)
- ASO Visual Abstract: Neoadjuvant Chemotherapy for Breast Cancer in the Elderly—Are We Accomplishing Our Treatment Goals? (2022) (0)
- Improving risk assessment of obesity-associated breast cancer. (2019) (0)
- ASO Visual Abstract: Effect of Age on Outcomes After Neoadjuvant Chemotherapy for Breast Cancer (2022) (0)
- Axillary management in early breast cancer: Surgeon attitudes in a population-based study. (2017) (0)
- ASO Visual Abstract: Is Nodal Clipping Beneficial for Node-Positive Breast Cancer Patients Receiving Neoadjuvant Chemotherapy? (2022) (0)
- Uncertainties and controversies in axillary management of patients with breast cancer. (2023) (0)
- Abstract P1-09-14: Breast carcinoma with 21-gene recurrence score lower than 18: Rate of distant metastases in a large series with clinical follow-up (2017) (0)
- Patient and tumor characteristics associated with contralateral breast cancer in a nested population-based case-control study. (2011) (0)
- Abstract P6-13-05: Frequency of delivery of systemic chemotherapy in elderly versus younger patients with triple negative breast cancer (2018) (0)
- Reply to S.M. Sorscher and A.B. Hafeez Bhatti. (2015) (0)
- Meta-analysis of Non-sentinel Node Metastases Associated With Micro-metastatic Sentinel Nodes in Breast Cancer (2006) (0)
- Primary chemotherapy for breast cancer: hope or hype? (1998) (0)
- Abstract P2-01-01: Prospective study of the need for axillary dissection and outcomes in Z11 eligible patients accounting for the use of nodal RT (2017) (0)
- ASO Visual Abstract: Can We Successfully Deescalate Axillary Surgery in Women Aged ≥ 70 Years with Ductal Carcinoma In Situ or Early-Stage Breast Cancer Undergoing Mastectomy? (2022) (0)
- Abstract 3139: Can PI3K/AKT pathway mutations predict for type of recurrence after conservative treatment for DCIS (2011) (0)
- Undissected Axilla and Axillary Radiotherapy-In Reply. (2019) (0)
- Adherence to breast cancer treatment guidelines according to pathogenic variants in cancer susceptibility genes in a population-based cohort. (2019) (0)
- Will surgery be a part of breast cancer treatment in the future? (2019) (0)
- Association of Radiation Timing with Long-Term Satisfaction and Health-Related Quality of Life in Prosthetic Breast Reconstruction (2022) (0)
- Leptin Mediates Obesity-Induced DNA Damage in BRCA1 Breast Epithelial Cells (2021) (0)
- Increasing rates of general anesthesia use in lumpectomy procedures: A 15‐year trends analysis (2023) (0)
- Carcinoma of the Skin (2002) (0)
- Docetaxel (Taxotere) in the Neoadjuvant Setting for Breast Cancer (1998) (0)
- A Prospective, Symptom Related, Outcomes Analysis of 1022 Palliative Procedures for Advanced CancerMiner TJ, Brennan MF, Jaques DP (Memorial-Sloan Kettering Cancer Ctr, New York; Brown Med School, Providence, RI) Ann Surg 240:719-727, 2004§ (2006) (0)
- ASO Author Reflections: Undertreatment of Early-Stage Breast Cancer in Elderly Women Undergoing Lumpectomy Without Radiotherapy Increases the Risk of Locoregional Recurrence (2022) (0)
- ASO Visual Abstract: Post-Discharge Non-Steroidal Anti-Inflammatory Drugs Are Not Associated with Risk of Hematoma After Lumpectomy and Sentinel Lymph Node Biopsy with Multimodal Analgesia (2021) (0)
- Carcinoma ductal in situ. Tratamiento actual (2007) (0)
- Patient access to breast reconstruction after mastectomy and long-term outcomes. (2011) (0)
- Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer (2007) (0)
- Recurrence rates for ductal carcinoma in situ: Analysis of 2,996 patients treated with breast-conserving surgery over 30 years. (2015) (0)
- ASO Author Reflections: To Dissect or Not to Dissect—The Clinical Implications of Microscopic Extracapsular Extension in the Sentinel Node (2020) (0)
- De-escalating Treatment for Ductal Carcinoma In Situ. (2021) (0)
- Improving the Reproducibility of Diagnosing Micrometastases and Isolated Tumor CellsCserni G (for the European Working Group for Breast Screening Pathology (Bacs-Kiskun County Teaching Hosp, Kecskemet, Hungary; et al) Cancer 103:358-367, 2005§ (2006) (0)
- Letter the editor (multiple letters) (2000) (0)
- Contralateral prophylactic mastectomy decision-making in the population-based iCanCare study of early-stage breast cancer patients. (2016) (0)
- Breast conservation for ductal carcinoma in situ: what is the risk? (1994) (0)
- SAT-339 Cross-Talk with Breast Adipose Tissue Contributes to Obesity-induced DNA Damage in BRCA Mutant Breast Epithelial Cells (2019) (0)
- In Brief (1997) (0)
- Impact of HER2 Status on Risk of Sentinel Node Metastasis: An Independently Validated Multivariable Model. (2009) (0)
- Carcinoma ductal in situ (2003) (0)
- ASO Visual Abstract: Impact of Endocrine Therapy Adherence on Outcomes in Elderly Women With Early-Stage Breast Cancer Undergoing Lumpectomy Without Radiotherapy (2022) (0)
This paper list is powered by the following services:
Other Resources About Monica Morrow
What Schools Are Affiliated With Monica Morrow?
Monica Morrow is affiliated with the following schools:
- University of Texas Southwestern Medical Center
- Massachusetts General Hospital
- University of Chicago
- Harvard University
- Pennsylvania State University
- University of Michigan
- Rockefeller University
- Cornell University
- MD Anderson Cancer Center
- Northwestern University
- Thomas Jefferson University
- McGill University
- Queen Mary University of London
